Search:
Tokushima UniversityGraduate School of Biomedical Sciences医学域Medical SciencePhysiological SciencesDepartment of Pharmacology
Tokushima UniversityFaculty of MedicineSchool of MedicineCourse of Biological MedicinePharmacology
(Files for researchmap) [PDF manual] [Auto-propagate to researchmap]

Research Activity

Personal Web Page

Field of Study

Life sciences [Clinical pharmacy]
Life sciences [Environmental and pharmaceutical development resources]
Life sciences [Cardiology]
Life sciences [Pharmacology]

Subject of Study

Book / Paper

Book:

1. Yasumasa Ikeda, 田島 壮一郎, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
腎とフリーラジカル第11集,
TOKYO IGAKUSHA, Tokyo, Jan. 2013.
2. Takumi Sakurada, Keisuke Ishizawa, Masaki Imanishi, Shoko Fujii, Jumpei Taniguchi, Yuki Izawa-Ishizawa, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
腎とフリーラジカル第11集,
TOKYO IGAKUSHA, Tokyo, Jan. 2013.
3. Keisuke Ishizawa, 三木 恵里加, Yuki Izawa-Ishizawa, 大西 秀樹, Narantungalag Dorjsuren, 元林 有紀, Kunihisa Yamaguchi, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
腎とフリーラジカル第9集,
TOKYO IGAKUSHA, Tokyo, Sep. 2008.

Academic Paper (Judged Full Paper):

1. Mitsuhiro Goda, Masaya Kanda, Toshihiko Yoshioka, Ami Yoshida, Yoichi Murai, Yoshito Zamami, Fuka Aizawa, Takahiro Niimura, Hirofumi Hamano, Naoto Okada, Kenta Yagi, Masayuki Chuma, Yuki Izawa-Ishizawa and Keisuke Ishizawa :
Effects of 5-HT3 receptor antagonists on cisplatin-induced kidney injury.,
Clinical and Translational Science, 2021.
(Tokushima University Institutional Repository: 116008,   DOI: 10.1111/cts.13045,   PubMed: 33982438)
2. Shimon Takahashi, Kenshi Takechi, Natsumi Jozukuri, Takahiro Niimura, Masayuki Chuma, Mitsuhiro Goda, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Koichiro Tsuchiya, Hiroaki Yanagawa and Keisuke Ishizawa :
Examination of the antiepileptic effects of valacyclovir using kindling mice- search for novel antiepileptic agents by drug repositioning using a large medical information database.,
European Journal of Pharmacology, Vol.902, 2021.
(Tokushima University Institutional Repository: 116301,   DOI: 10.1016/j.ejphar.2021.174099,   PubMed: 33910036)
3. Kenta Yagi, Marin Mitstui, Yoshito Zamami, Takahiro Niimura, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Masayuki Chuma, Kimiko Fukunaga, Takahiro Shibata, Shunsuke Ishida, Takumi Sakurada, Naoto Okada, Hirofumi Hamano, Yuya Horinouchi, Yasumasa Ikeda, Hiroaki Yanagawa and Keisuke Ishizawa :
Investigation of drugs affecting hypertension in bevacizumab-treated patients and examination of the impact on the therapeutic effect.,
Cancer Medicine, 2020.
(Tokushima University Institutional Repository: 116288,   DOI: 10.1002/cam4.3587,   PubMed: 33231381)
4. Kondo Masateru, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Hosooka Mayuko, Kagimoto Yuu, Saito Naoko, Matsuoka Rie, Yoshito Zamami, Masayuki Chuma, Kenta Yagi, Kenshi Takechi, Koichi Tsuneyama and Keisuke Ishizawa :
Preventive Effects of Quercetin against the Onset of Atherosclerosis-Related Acute Aortic Syndromes in Mice,
International Journal of Molecular Sciences, Vol.21, No.19, 2020.
(Tokushima University Institutional Repository: 115332,   DOI: 10.3390/ijms21197226,   Elsevier: Scopus)
5. Yasumasa Ikeda, Hiroaki Watanabe, Tetsuya Shiuchi, Hirofumi Hamano, Yuya Horinouchi, Masaki Imanishi, Mitsuhiro Goda, Yoshito Zamami, Kenshi Takechi, Yuki Izawa-Ishizawa, Licht Miyamoto, Keisuke Ishizawa, Ken-ichi Aihara, Koichiro Tsuchiya and Toshiaki Tamaki :
Deletion of H-ferritin in macrophages alleviates obesity and diabetes induced by high-fat diet in mice,
Diabetologia, Vol.63, No.8, 1588-1602, 2020.
(Tokushima University Institutional Repository: 114409,   DOI: 10.1007/s00125-020-05153-0,   PubMed: 32430665,   Elsevier: Scopus)
6. Masaki Imanishi, Yusuke Yamakawa, Keijo Fukushima, Raiki Ikuto, Akiko Maegawa, Yuki Izawa-Ishizawa, Yuya Horinouchi, Masateru Kondo, Masatoshi Kishuku, Mitsuhiro Goda, Yoshito Zamami, Kenshi Takechi, Masayuki Chuma, Yasumasa Ikeda, Koichiro Tsuchiya, Hiromichi Fujino, Koichi Tsuneyama and Keisuke Ishizawa :
Fibroblast-specific ERK5 deficiency changes tumor vasculature and exacerbates tumor progression in a mouse model.,
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.393, No.7, 1239-1250, 2020.
(DOI: 10.1007/s00210-020-01859-5,   PubMed: 32307577)
7. Tatsuya Tsuda, Masaki Imanishi, Mizuho Oogoshi, Mitsuhiro Goda, Yoshitaka Kihira, Yuya Horinouchi, Yoshito Zamami, Keisuke Ishizawa, Yasumasa Ikeda, Ichiro Hashimoto, Toshiaki Tamaki and Yuki Izawa-Ishizawa :
Rho-associated protein kinase and cyclophilin a are involved in inorganic phosphate-induced calcification signaling in vascular smooth muscle cells.,
Journal of Pharmacological Sciences, Vol.142, No.3, 109-115, 2020.
(Tokushima University Institutional Repository: 115530,   DOI: 10.1016/j.jphs.2019.12.005,   PubMed: 31882204)
8. Hirofumi Hamano, Takahiro Niimua, Yuya Horinouchi, Yoshito Zamami, Kenshi Takechi, Mitsuhiro Goda, Masaki Imanishi, Masayuki Chuma, Yuki Izawa-Ishizawa, Licht Miyamoto, Keijo Fukushima, Hiromichi Fujino, Koichiro Tsuchiya, Keisuke Ishizawa, Toshiaki Tamaki and Yasumasa Ikeda :
Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway,
Toxicology Letters, Vol.318, 86-91, 2020.
(Tokushima University Institutional Repository: 113812,   DOI: 10.1016/j.toxlet.2019.10.016,   PubMed: 31669099)
9. Yoshito Zamami, Takahiro Niimura, Toshihiro Koyama, Yuta Shigemi, Yuki Izawa-Ishizawa, Mizuki Morita, Ayako Ohshima, Keisaku Harada, Toru Imai, Hiromi Hagiwara, Naoto Okada, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Yutaka Kondo, Koichiro Tsuchiya, Shiro Hinotsu, R Mitsunobu Kano and Keisuke Ishizawa :
Search for Therapeutic Agents for Cardiac Arrest Using a Drug Discovery Tool and Large-Scale Medical Information Database.,
Frontiers in Pharmacology, Vol.10, 2019.
(Tokushima University Institutional Repository: 114461,   DOI: 10.3389/fphar.2019.01257,   PubMed: 31780928,   Elsevier: Scopus)
10. Yoshito Zamami, Takahiro Niimura, Naoto Okada, Toshihiro Koyama, Keijo Fukushima, Yuki Izawa-Ishizawa and Keisuke Ishizawa :
Factors Associated With Immune Checkpoint Inhibitor-Related Myocarditis.,
JAMA Oncology, 2019.
(DOI: 10.1001/jamaoncol.2019.3113,   PubMed: 31436802)
11. Yasumasa Ikeda, Akiho Satoh, Yuya Horinouchi, Hirofumi Hamano, Hiroaki Watanabe, Mizuki Imao, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Yuki Izawa-Ishizawa, Licht Miyamoto, Hirayama Tasuku, Hideko Nagasawa, Keisuke Ishizawa, Ken-ichi Aihara, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress,
The FASEB journal, Vol.33, No.8, 9551-9564, 2019.
(Tokushima University Institutional Repository: 113746,   DOI: 10.1096/fj.201802724RR,   PubMed: 31145863)
12. Hirofumi Hamano, Marin Mitsui, Yoshito Zamami, Kenshi Takechi, Takahiro Nimura, Naoto Okada, Keijo Fukushima, Masaki Imanishi, Masayuki Chuma, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasushi Kirino, Toshimi Nakamura, Kazuhiko Teraoka, Yasumasa Ikeda, Hiromichi Fujino, Hiroaki Yanagawa, Toshiaki Tamaki and Keisuke Ishizawa :
Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database.,
Supportive Care in Cancer, Vol.27, No.3, 849-856, 2019.
(DOI: 10.1007/s00520-018-4367-y,   PubMed: 30062585)
13. Masateru Kondo, Masaki Imanishi, Keijo Fukushima, Raiki Ikuto, Yoichi Murai, Yuya Horinouchi, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Yoshito Zamami, Kenshi Takechi, Masayuki Chuma, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya and Keisuke Ishizawa :
Xanthine Oxidase Inhibition by Febuxostat in Macrophages Suppresses Angiotensin II-induced Aortic Fibrosis.,
American Journal of Hypertension, Vol.32, No.3, 249-256, 2019.
(DOI: 10.1093/ajh/hpy157,   PubMed: 30351343)
14. Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Toya Hiroki, Nagao Tomoko, Marin Morishita, Koichi Tsuneyama, Yuya Horinouchi, Yoshitaka Kihira, Kenshi Takechi, Yasumasa Ikeda, Koichiro Tsuchiya, Masanori Yoshizumi, Toshiaki Tamaki and Keisuke Ishizawa :
Development of a novel aortic dissection mouse model and evaluation of drug efficacy using in-vivo assays and database analyses.,
Journal of Hypertension, Vol.37, No.1, 73-83, 2019.
(Tokushima University Institutional Repository: 113264,   DOI: 10.1097/HJH.0000000000001898,   PubMed: 30303488)
15. Masaki Imanishi, Yuki Izawa-Ishizawa, T Sakurada, Y Kohara, Yuya Horinouchi, E Sairyo, Yoshito Zamami, Kenshi Takechi, Masayuki Chuma, Keijo Fukushima, Yasumasa Ikeda, Hiromichi Fujino, M Yoshizumi, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
Nitrosonifedipine, a Photodegradation Product of Nifedipine, Suppresses Pharmacologically Induced Aortic Aneurysm Formation.,
Pharmacology, Vol.102, No.5-6, 281-286, 2018.
(DOI: 10.1159/000492577,   PubMed: 30253416,   Elsevier: Scopus)
16. Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Masaki Imanishi, Hirofumi Hamano, Yuki Izawa-Ishizawa, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis.,
Scientific Reports, Vol.8, No.1, 2018.
(Tokushima University Institutional Repository: 112445,   DOI: 10.1038/s41598-018-29008-2,   PubMed: 30022146)
17. Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease,
Nephrology, Dialysis, Transplantation, Vol.33, No.4, 586-597, 2018.
(Tokushima University Institutional Repository: 110922,   DOI: 10.1093/ndt/gfx252,   PubMed: 28992067)
18. Takahiro Niimura, Yoshito Zamami, Toshihiro Koyama, Yuki Izawa-Ishizawa, Masashi Miyake, Tadashi Koga, Keisaku Harada, Ayako Ohshima, Toru Imai, Yutaka Kondo, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki, Shiro Hinotsu, R Mitsunobu Kano and Keisuke Ishizawa :
Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest.,
Scientific Reports, Vol.7, No.1, 2017.
(Tokushima University Institutional Repository: 112397,   DOI: 10.1038/s41598-017-17686-3,   PubMed: 29263333)
19. Shiho Sato, Yoshito Zamami, Toru Imai, Satoshi Tanaka, Toshihiro Koyama, Takahiro Niimura, Masayuki Chuma, Tadashi Koga, Kenshi Takechi, Yasuko Kurata, Yutaka Kondo, Yuki Izawa-Ishizawa, Toshiaki Sendo, Hironori Nakura and Keisuke Ishizawa :
Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia.,
Scientific Reports, Vol.7, No.1, 2017.
(Tokushima University Institutional Repository: 112393,   DOI: 10.1038/s41598-017-13073-0,   PubMed: 28978927,   Elsevier: Scopus)
20. Yasumasa Ikeda, Yuya Horinouchi, Hamano Hirofumi, Hirayama Tasuku, Seiji Kishi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Ken-ichi Aihara, Hideko Nagasawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice,
Scientific Reports, Vol.7, No.1, 10621, 2017.
(Tokushima University Institutional Repository: 112368,   DOI: 10.1038/s41598-017-11089-0,   PubMed: 28878231)
21. Keisuke Oshima, Yasumasa Ikeda, Yuya Horinouchi, Hiroaki Watanabe, Hirofumi Hamano, Yoshitaka Kihira, Seiji Kishi, Yuki Izawa-Ishizawa, Licht Miyamoto, Tasuku Hirayama, Hideko Nagasawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron suppresses erythropoietin expression via oxidative stress-dependent hypoxia-inducible factor-2 alpha inactivation,
Laboratory Investigation; a Journal of Technical Methods and Pathology, Vol.97, No.5, 555-566, 2017.
(Tokushima University Institutional Repository: 113749,   DOI: 10.1038/labinvest.2017.11,   PubMed: 28263291)
22. Yutaka Fukunaga, Yuki Izawa-Ishizawa, Yuya Horinouchi, Eriko Sairyo, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya, Yoshiro Abe, Ichiro Hashimoto and Toshiaki Tamaki :
Topical Application of Nitrosonifedipine, a Novel Radical Scavenger, Ameliorates Ischemic Skin Flap Necrosis in a Mouse Model.,
Wound Repair and Regeneration, Vol.25, No.2, 217-223, 2017.
(Tokushima University Institutional Repository: 110118,   DOI: 10.1111/wrr.12510,   PubMed: 28090711)
23. Yasumasa Ikeda, Mizuki Imao, Akiho Satoh, Hiroaki Watanabe, Hirofumi Hamano, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway,
Journal of Trace Elements in Medicine and Biology, Vol.35, No.5, 66-76, 2016.
(Tokushima University Institutional Repository: 113750,   DOI: 10.1016/j.jtemb.2016.01.011,   PubMed: 27049128)
24. Yasumasa Ikeda, Hirofumi Hamano, Akiho Satoh, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Ken-ichi Aihara, Koichiro Tsuchiya and Toshiaki Tamaki :
Bilirubin exerts pro-angiogenic effects through an Akt-eNOS-dependent pathway,
Hypertension Research, Vol.38, No.11, 733-740, 2015.
(Tokushima University Institutional Repository: 113751,   DOI: 10.1038/hr.2015.74,   PubMed: 26134126,   Elsevier: Scopus)
25. Soichiro Tajima, Yasumasa Ikeda, Hideaki Enomoto, Mizuki Imao, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice,
European Journal of Nutrition, Vol.54, No.5, 709-719, 2015.
(Tokushima University Institutional Repository: 113753,   DOI: 10.1007/s00394-014-0749-1,   PubMed: 25096756,   Elsevier: Scopus)
26. Yoshitaka Kihira, Ariunzaya Burentogtokh, Mari Itoh, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia decreases glucagon-like peptide-1 secretion from GLUTag cell line,
Biological & Pharmaceutical Bulletin, Vol.38, No.4, 514-521, 2015.
(Tokushima University Institutional Repository: 109948,   DOI: 10.1248/bpb.b14-00612,   PubMed: 25832631,   CiNii: 130005062264,   Elsevier: Scopus)
27. Noriko Yamano, Yasumasa Ikeda, Minoru Sakama, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Licht Miyamoto, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
A Long-Term High-Fat Diet Changes Iron Distribution in Body, Increasing Iron Accumulation Specifically in the Mouse Spleen,
Journal of Nutritional Science and Vitaminology, Vol.61, No.1, 20-27, 2015.
(DOI: 10.3177/jnsv.61.20,   PubMed: 25994136,   CiNii: 40020377946,   Elsevier: Scopus)
28. Nhat-Tu Le, Yuichiro Takei, Yuki Izawa-Ishizawa, Kyung-Sun Heo, Hakjoo Lee, V Alan Smrcka, L Benjamin Miller, Ae Kyung Ko, Sara Ture, Craig Morrell, Keigi Fujiwara, Masashi Akaike and Jun-Ichi Abe :
Identification of Activators of ERK5 Transcriptional Activity by High-Throughput Screening and the Role of Endothelial ERK5 in Vasoprotective Effects Induced by Statins and Antimalarial Agents.,
The Journal of Immunology, Vol.193, No.7, 3803-3815, 2014.
(DOI: 10.4049/jimmunol.1400571,   PubMed: 25187658)
29. Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Masaki Ueno, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Noriko Yamano, Koichiro Tsuchiya and Toshiaki Tamaki :
Smooth muscle cell specific Hif-1 deficiency suppresses angiotensin II-induced vascular remodeling in mice,
Cardiovascular Research, Vol.102, No.3, 460-468, 2014.
(Tokushima University Institutional Repository: 106145,   DOI: 10.1093/cvr/cvu061,   PubMed: 24623277,   Elsevier: Scopus)
30. Atsushi Morimoto, Shuhei Tomita, Masaki Imanishi, Go Shioi, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Mitsuru Takaku, Ichiro Hashimoto, Yasumasa Ikeda, Hideki Nakanishi and Toshiaki Tamaki :
Overexpressed HIF-2α in Endothelial Cells Promotes Vascularization and Improves Random Pattern Skin Flap Survival.,
Plastic and Reconstructive Surgery. Global Open, Vol.2, No.4, e132, 2014.
(Tokushima University Institutional Repository: 106138,   DOI: 10.1097/GOX.0000000000000083,   PubMed: 25289325,   Elsevier: Scopus)
31. Yoshitaka Kihira, Mariko Miyake, Manami Hirata, Yoji Hoshina, Kana Kato, Hitoshi Shirakawa, Hiroshi Sakaue, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Deletion of hypoxia-inducible factor-1α in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue inflammation.,
PLoS ONE, Vol.9, No.4, e93856, 2014.
(DOI: 10.1371/journal.pone.0093856,   PubMed: 24705496,   Elsevier: Scopus)
32. Yasumasa Ikeda, Iori Ozono, Soichro Tajima, Mizuki Imao, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction,
PLoS ONE, Vol.9, No.2, e89355, 2014.
(Tokushima University Institutional Repository: 113752,   DOI: 10.1371/journal.pone.0089355,   PubMed: 24586712,   Elsevier: Scopus)
33. Keisuke Ishizawa, Yuki Izawa-Ishizawa, Noriko Yamano, Maki Urushihara, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Asami Nuno, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Shoji Kagami, Hiroyuki Kobori, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects,
PLoS ONE, Vol.9, No.1, e86335, 2014.
(DOI: 10.1371/journal.pone.0086335,   PubMed: 24489716,   Elsevier: Scopus)
34. Yasumasa Ikeda, Hideaki Enomoto, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Dietary iron restriction inhibits progression of diabetic nephropathy in db/db mice.,
American Journal of Physiology, Renal Physiology, Vol.304, No.7, F1028-F1036, 2013.
(DOI: 10.1152/ajprenal.00473.2012,   PubMed: 23389454)
35. Yasumasa Ikeda, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Sumiko Yoshida, Ken-ichi Aihara, Koichiro Tsuchiya and Toshiaki Tamaki :
Bovine milk-derived lactoferrin exerts proangiogenic effects in an Src-Akt-eNOS-dependent manner in response to ischemia,
Journal of Cardiovascular Pharmacology, Vol.61, No.5, 423-429, 2013.
(Tokushima University Institutional Repository: 113754,   DOI: 10.1097/FJC.0b013e318287d526,   PubMed: 23364610)
36. Takumi Sakurada, Keisuke Ishizawa, Masaki Imanishi, Yuki Izawa-Ishizawa, Shoko Fujii, Erika Tominaga, Teppei Tsuneishi, Yuya Horinouchi, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Ken-ichi Aihara, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects,
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.386, No.1, 29-39, 2013.
(DOI: 10.1007/s00210-012-0810-7,   PubMed: 23149861,   Elsevier: Scopus)
37. Yuki Izawa-Ishizawa, Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Licht Miyamoto, Shoko Fujii, Hironori Taira, Yoshitaka Kihira, Yasumasa Ikeda, Shuichi Hamano, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin II receptor blocker improves tumor necrosis factor-α-induced cytotoxicity via antioxidative effect in human glomerular endothelial cells,
Pharmacology, Vol.90, No.5-6, 324-331, 2012.
(DOI: 10.1159/000343244,   PubMed: 23052181,   Elsevier: Scopus)
38. Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Takashi Iwase, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya, Masataka Sata, Masashi Akaike, Shigeaki Kato, Toshio Matsumoto and Toshiaki Tamaki :
Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway,
The Journal of Biological Chemistry, Vol.287, No.41, 34256-34263, 2012.
(DOI: 10.1074/jbc.M112.353532,   PubMed: 22904320)
39. Yasumasa Ikeda, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes,
PLoS ONE, Vol.7, No.7, e40465, 2012.
(DOI: 10.1371/journal.pone.0040465,   PubMed: 22792339,   Elsevier: Scopus)
40. Soichiro Tajima, Yasumasa Ikeda, Kaori Sawada, Noriko Yamano, Yuya Horinouchi, Yoshitaka Kihira, Keisuke Ishizawa, Yuki Izawa-Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice.,
American Journal of Physiology, Endocrinology and Metabolism, Vol.302, No.1, E77-86, 2012.
(DOI: 10.1152/ajpendo.00033.2011,   PubMed: 21917632)
41. Yoshitaka Kihira, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Basic fibroblast growth factor regulates glucose metabolism through glucose transporter 1 induced by hypoxia-inducible factor-1α in adipocytes,
The International Journal of Biochemistry & Cell Biology, Vol.43, No.11, 1602-1611, 2011.
(DOI: 10.1016/j.biocel.2011.07.009,   PubMed: 21810481)
42. Keisuke Ishizawa, Yuki Izawa-Ishizawa, Narantungalag Dorjsuren, Erika Miki, Yoshitaka Kihira, Yasumasa Ikeda, Shuichi Hamano, Kazuyoshi Kawazoe, Kazuo Minakuchi, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin II receptor blocker attenuates PDGF-induced mesangial cell migration in a receptor-independent manner,
Nephrology, Dialysis, Transplantation, Vol.25, No.2, 364-372, 2010.
(DOI: 10.1093/ndt/gfp520,   PubMed: 19812233)
43. Hirotsugu Kurobe, Masahisa Urata, Masaki Ueno, Masaaki Ueki, Shiro Ono, Yuki Izawa-Ishizawa, Yayoi Fukuhara, Yu Lei, Adiratna Mat Ripen, Tamotsu Kanbara, Ken-ichi Aihara, Keisuke Ishizawa, Masashi Akaike, Frank J. Gonzalez, Toshiaki Tamaki, Yousuke Takahama, Masanori Yoshizumi, Tetsuya Kitagawa and Shuhei Tomita :
Role of Hypoxia-Inducible Factor 1α in T Cells as a Negative Regulator in Development of Vascular Remodeling,
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol.30, No.2, 210-217, 2010.
(DOI: 10.1161/ATVBAHA.109.192666,   PubMed: 20007912)
44. Keisuke Ishizawa, Narantungalag Dorjsuren, Yuki Izawa-Ishizawa, Rika Sugimoto, Yasumasa Ikeda, Yoshitaka Kihira, Kazuyoshi Kawazoe, Shuhei Tomita, Koichiro Tsuchiya, Kazuo Minakuchi and Toshiaki Tamaki :
Inhibitory effects of adiponectin on platelet-derived growth factor-induced mesangial cell migration,
The Journal of Endocrinology, Vol.202, No.2, 309-316, 2009.
(DOI: 10.1677/JOE-08-0469,   PubMed: 19460854)
45. Yuki Motobayashi, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Sakiko Orino, Kunihisa Yamaguchi, Kazuyoshi Kawazoe, Shuichi Hamano, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells,
Hypertension Research, Vol.32, No.3, 188-193, 2009.
(DOI: 10.1038/hr.2008.19,   PubMed: 19262481)
46. Keisuke Ishizawa, Yuki Izawa-Ishizawa, Sachiyo Ohnishi, Yuki Motobayashi, Kazuyoshi Kawazoe, Shuichi Hamano, Koichiro Tsuchiya, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
Quercetin Glucuronide Inhibits Cell Migration and Proliferation by Platelet-Derived Growth Factor in Vascular Smooth Muscle Cells,
Journal of Pharmacological Sciences, Vol.109, No.2, 257-264, 2009.
(DOI: 10.1254/jphs.08236FP,   PubMed: 19202317)
47. Yasuhisa Kanematsu, Kunihisa Yamaguchi, Hideki Ohnishi, Yuki Motobayashi, Keisuke Ishizawa, Yuki Izawa, Kazuyoshi Kawazoe, Shuji Kondo, Shoji Kagami, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Dietary doses of nitrite restore circulating nitric oxide level and improve renal injury in L-NAME-induced hypertensive rats,
American Journal of Physiology, Renal Physiology, Vol.295, No.5, F1457-F1462, 2008.
(DOI: 10.1152/ajprenal.00621.2007,   PubMed: 18753302)
48. Yuki Izawa, Masanori Yoshizumi, Keisuke Ishizawa, Yoshiko Fujita, Shuji Kondo, Shoji Kagami, Kazuyoshi Kawazoe, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
Big mitogen-activated protein kinase 1 (BMK1)/extracellular signal regulated kinase 5 (ERK5) is involved in platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell migration,
Hypertension Research, Vol.30, No.11, 1107-1117, 2007.
(DOI: 10.1291/hypres.30.1107,   PubMed: 18250560)
49. Yasuhisa Kanematsu, Koichiro Tsuchiya, Hideki Onishi, Yuki Motobayashi, Yuki Izawa, Manabu Ishihara, Keisuke Ishizawa, Shinji Abe, Kazuyoshi Kawazoe and Toshiaki Tamaki :
Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in Nω-nitro-L-arginine methyl ester-treated rats,
Hypertension Research, Vol.29, No.5, 369-374, 2006.
(DOI: 10.1291/hypres.29.369,   PubMed: 16832158)
50. Yoshiko Fujita, Masanori Yoshizumi, Yuki Izawa, Nermin Ali, Yasuhisa Kanematsu, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation.,
Endocrinology, Vol.147, No.3, 1377-1385, 2006.
(DOI: 10.1210/en.2005-0644,   PubMed: 16322069,   Elsevier: Scopus)
51. Yoshiko Fujita, Yuki Izawa, Nermin Ali, Koichiro Tsuchiya, Shuichi Hamano, Toshiaki Tamaki and Masanori Yoshizumi :
Pramipexole protects against H2O2-induced PC12 cell death,
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.372, No.4, 257-266, 2006.
(DOI: 10.1007/s00210-005-0025-2,   PubMed: 16362428,   Elsevier: Scopus)
52. Hiroyuki Sakakibara, Kaori Ishida, Yuki Izawa, Yuko Minami, Satomi Saito, Yoshichika Kawai, Veronika Butterweck, Toshiaki Tamaki, Yutaka Nakaya and Junji Terao :
Effects of forced swimming stress on rat brain function,
The Journal of Medical Investigation : JMI, Vol.52, No.Suppl., 300-3001, 2005.
(Tokushima University Institutional Repository: 111587,   DOI: 10.2152/jmi.52.300,   PubMed: 16366521)
53. Yuki Izawa, Masanori Yoshizumi, Keisuke Ishizawa, Yoshiko Fujita, Shuji Kondo, Shoji Kagami, Kazuyoshi Kawazoe, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells,
Experimental Cell Research, Vol.308, No.2, 291-299, 2005.
(DOI: 10.1016/j.yexcr.2005.04.028,   PubMed: 15921682)
54. Keisuke Ishizawa, Yuki Izawa, Hiroyuki Ito, Chieko Miki, Kayoko Miyama, Yoshiko Fujita, Yasuhisa Kanematsu, Koichiro Tsuchiya, Toshiaki Tamaki, Akira Nishiyama and Masanori Yoshizumi :
Aldosterone stimulates vascular smooth muscle cell proliferation via big mitoten-activated protein kinase 1 activation,
Hypertension, Vol.46, No.4, 1046-1052, 2005.
(DOI: 10.1161/01.HYP.0000172622.51973.f5,   PubMed: 16087789)
55. Yasumasa Ikeda, Ken-ichi Aihara, Takashi Sato, Masashi Akaike, Masanori Yoshizumi, Yuki Suzaki, Yuki Izawa-Ishizawa, Mitsunori Fujimura, Shunji Hashizume, Midori Kato, Shusuke Yagi, Toshiaki Tamaki, Hirotaka Kawano, Takahiro Matsumoto, Hiroyuki Azuma, Shigeaki Kato and Toshio Matsumoto :
Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis.,
The Journal of Biological Chemistry, Vol.280, No.33, 29661-29666, 2005.
(DOI: 10.1074/jbc.M411694200,   PubMed: 15961403)
56. Ali Nermin, Masanori Yoshizumi, Yoshiko Fujita, Yuki Izawa, Yasuhisa Kanematsu, Keisuke Ishizawa, Koichiro Tsuchiya, Seiji Yano, Saburo Sone and Toshiaki Tamaki :
A Novel Src Kinase Inhibitor, M475271, Inhibits VEGF-Induced Human Umbilical Vein Endothelial Cell Proliferation and Migration,
Journal of Pharmacological Sciences, Vol.98, No.2, 130-141, 2005.
(DOI: 10.1254/jphs.FP0040850,   PubMed: 15937404)
57. Koichiro Tsuchiya, Yasuhisa Kanematsu, Masanori Yoshizumi, Hideki Ohnishi, Kazuyoshi Kirima, Yuki Izawa, Michiyo Shikishima, Tatsuhiro Ishida, Shuji Kondo, Shoji Kagami, Yoshiharu Takiguchi and Toshiaki Tamaki :
Nitrite is an alternative source of NO in vivo,
American Journal of Physiology, Heart and Circulatory Physiology, Vol.288, No.5, H2163-H2170, 2005.
(DOI: 10.1152/ajpheart.00525.2004,   PubMed: 15626692)
58. Masumi Okamoto, Koichiro Tsuchiya, Yasuhisa Kanematsu, Yuki Izawa, Masanori Yoshizumi, Susumu Kagawa and Toshiaki Tamaki :
Nitrite-derived nitric oxide formation following ischemia-reperfusion injyury in kidney.,
American Journal of Physiology, Renal Physiology, Vol.288, No.1, 182-187, 2005.
(DOI: 10.1152/ajprenal.00036.2004,   PubMed: 15367387)
59. Koichiro Tsuchiya, Yoshiharu Takiguchi, Masumi Okamoto, Yuki Izawa, Yasuhisa Kanematsu, Masanori Yoshizumi and Toshiaki Tamaki :
Malfunction of vascular control in lifestyle-related diseases : formation of systemic hemoglobin-nitric oxide Complex(HbNO) From Dietary Nitrite,
Journal of Pharmacological Sciences, Vol.96, No.4, 395-400, 2004.
(DOI: 10.1254/jphs.FMJ04006X3,   PubMed: 15599101)
60. Moe Kyaw, Masanori Yoshizumi, Koichiro Tsuchiya, Yuki Izawa, Yasuhisa Kanematsu, Yoshiko Fujita, Nermin Ali, Keisuke Ishizawa, Aiko Yamauchi and Toshiaki Tamaki :
Antioxidant effects of stereoisomers of N-acetylcysteine (NAC), L-NAC and D-NAC, on angiotensin II-stimulated MAP kinase activation and vascular smooth muscle cell proliferation,
Journal of Pharmacological Sciences, Vol.95, No.4, 483-486, 2004.
(DOI: 10.1254/jphs.SC0040061,   PubMed: 15297771)
61. Moe Kyaw, Masanori Yoshizumi, Koichiro Tsuchiya, Yuki Izawa, Yasuhisa Kanematsu and Toshiaki Tamaki :
Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases,
Acta Pharmacologica Sinica, Vol.25, No.8, 977-985, 2004.
(PubMed: 15301727)
62. Keisuke Ishizawa, Masanori Yoshizumi, Koichiro Tsuchiya, Hitoshi Houchi, Kazuo Minakuchi, Yuki Izawa, Yasuhisa Kanematsu, Shoji Kagami, Masao Hirose and Toshiaki Tamaki :
Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells,
Hypertension Research, Vol.27, No.6, 433-440, 2004.
(DOI: 10.1291/hypres.27.433,   PubMed: 15253109)
63. Yuki Suzaki, Masanori Yoshizumi, Shoji Kagami, Akira Nishiyama, Yuichi Ozawa, Moe Kyaw, Yuki Izawa, Yasuhisa Kanematsu, Koichiro Tsuchiya and Toshiaki Tamaki :
BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions,
Kidney International, Vol.65, No.5, 1749-1760, 2004.
(DOI: 10.1111/j.1523-1755.2004.00576.x,   PubMed: 15086914)
64. Moe Kyaw, Masanori Yoshizumi, Koichiro Tsuchiya, Shoji Kagami, Yuki Izawa, Yoshiko Fujita, Nermin Ali, Yasuhisa Kanematsu, Kazunori Toida, Kazunori Ishimura and Toshiaki Tamaki :
Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cell via extracellur signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation,
Molecular Pharmacology, Vol.65, No.4, 832-841, 2004.
(DOI: 10.1124/mol.65.4.832,   PubMed: 15044612)
65. Masanori Yoshizumi, Yoshiko Fujita, Yuki Izawa, Yuki Suzaki, Moe Kyaw, Nermin Ali, Koichiro Tsuchiya, Shoji Kagami, Seiji Yano, Saburo Sone and Toshiaki Tamaki :
Ebselen inhibits tumor necrosis factor-α-induced c-jun N-terminal kinase activation and adhesion molecule expression in endothelial cells,
Experimental Cell Research, Vol.292, No.1, 1-10, 2004.
(DOI: 10.1016/j.yexcr.2003.08.003,   PubMed: 14720501,   CiNii: 80016399784)
66. Nermin Ali, Masanori Yoshizumi, Koichiro Tsuchiya, Moe Kyaw, Yoshiko Fujita, Yuki Izawa, Shinji Abe, Yasuhisa Kanematsu, Shoji Kagami and Toshiaki Tamaki :
Ebsalen inhibits p38MAP kinase-mediated endothelial cell death by hydrogen peroxide.,
European Journal of Pharmacology, Vol.485, No.1-3, 127-135, 2004.
(DOI: 10.1016/j.ejphar.2003.11.079,   PubMed: 14757132)

Academic Paper (Unrefereed Paper):

1. Yoshiko Fujita, Masanori Yoshizumi, Yuki Izawa, Yasuhisa Kanematsu and Toshiaki Tamaki :
Lysophosphatidylcholine(LPC)transactivates vascular endothelial growth factor(VEGF) receptor via c-Src in HUVEC,
Shikoku Acta Medica, Vol.61, No.3,4, 91-94, 2005.
(Tokushima University Institutional Repository: 47262,   CiNii: 40007059225)

Review, Commentary:

1. Masaki Imanishi, Keisuke Ishizawa, TAKUMI SAKURADA, Yuki Izawa-Ishizawa, Noriko Yamano, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Drug development for cardiorenal disease based on oxidative stress control,
Journal of the Pharmaceutical Society of Japan, Vol.134, No.6, 715-719, Jun. 2014.
(DOI: 10.1248/yakushi.13-00255-4,   PubMed: 24882646)
2. Masaki Imanishi, Keisuke Ishizawa, 櫻田 巧, Yuki Izawa-Ishizawa, Noriko Yamano, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
酸化ストレス制御を基盤とする新規心腎血管障害治療薬の開発,
Journal of the Pharmaceutical Society of Japan, Vol.134, No.6, 715-719, 2014.
3. 櫻田 巧, Keisuke Ishizawa, Masaki Imanishi, 藤井 聖子, 谷口 順平, Yuki Izawa-Ishizawa, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipineはangiotensin IIによるマウス血管リモデリングを抑制する,
腎とフリーラジカル, Vol.11, 78-81, Jan. 2013.
4. Masanori Yoshizumi, Keisuke Ishizawa, Yuki Izawa and Toshiaki Tamaki :
Intracellular signal transduction of vascular injury in insulin resistance,
Folia Pharmacologica Japonica, Vol.128, No.3, 147-151, Sep. 2006.
(DOI: 10.1254/fpj.128.147,   PubMed: 16971777,   CiNii: 10018399832)

Proceeding of International Conference:

1. Yoshito Zamami, Yuki Izawa-Ishizawa, Takahiro Niimura, Mitsuhiro Goda, Naoto Okada, Kenshi Takechi, Masayuki Chuma, Keijo Fukushima, Yasumasa Ikeda, Koichiro Tsuchiya and Keisuke Ishizawa :
Development of therapeutic agents using drug discovery tools and large-scale medical information,
FIP2019, Abu Dhabi, Sep. 2019.
2. Niimura Takahiro, Yoshito Zamami, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Keijo Fukushima, Yuya Horinouchi, Hiromichi Fujino, Koichiro Tsuchiya and Keisuke Ishizawa :
Nicorandil improve prognosis of cardiac arrest patient: A large-scale medical information analysis,
FIP2019, Abu Dhabi, Sep. 2019.
3. Mitsuhiro Goda, Kazuhito Saike, Takahiro Niimura, Masaya Kanda, Kenshi Takechi, Masayuki Chuma, Yuki Izawa-Ishizawa, Yoshito Zamami and Keisuke Ishizawa :
Effect of new preventive medicine on cisplatin-induced acute kidney injury,
EACPT2019, Stockholm, Jun. 2019.
4. Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Utilizing Real-World Big Data in the Search for New Renoprotective Drugs,
Joint Hypertension 2018 Scientific Sessions, Sep. 2018.
5. Yoshito Zamami, Yuki Izawa-Ishizawa, Takahiro Niimura, Kenshi Takechi, Masaki Imanishi, Masayuki Chuma, Yuya Horinouchi, Yasumasa Ikeda, Koichiro Tsuchiya and Keisuke Ishizawa :
Drug repositioning for post cardiopulmonary resuscitation syndrome using large-scale medical claims,
FIP2018, グラスゴー, Sep. 2018.
6. Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Renoprotective effects of edoxaban, a factor Xa inhibitor,
18th World Congress of Basic and Clinical Pharmacology, Jul. 2018.
7. Yuki Izawa-Ishizawa, Masaki Imanishi, kotoko suzuki, Yuya Horinouchi, Kenshi Takechi, Yoshito Zamami, Koichiro Tsuchiya, Toshiaki Tamaki, Keisuke Ishizawa and Yasumasa Ikeda :
The effect of quercetin on aortic aneurysms in mice,
WCP2018, Jul. 2018.
8. 濱野 裕章, Yasumasa Ikeda, Yuya Horinouchi, Yoshito Zamami, Masaki Imanishi, Yuki Izawa-Ishizawa, Licht Miyamoto, Koichiro Tsuchiya, Keisuke Ishizawa and Toshiaki Tamaki :
Proton Pump Inhibitor Involves Abnormality of Iron Metabolism through Hepcidin Regulation,
18th World Congress of Basic and Clinical Pharmacology, Jul. 2018.
9. Yoshito Zamami, Yuki Izawa-Ishizawa, Kenshi Takechi, Masaki Imanishi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Toshiaki Tamaki and Keisuke Ishizawa :
Search for drugs that attenuate the anti tumor effect of bevacizumab using adverse event database,
18th World Congress of Basic and Clinical Pharmacology, Jul. 2018.
10. Yoshito Zamami, Takahiro Niimura, Yuki Izawa-Ishizawa, Kenshi Takechi, Masaki Imanishi, Krino Yashishi, Nakamura Toshimi, Teraoka Kazuhiko and Keisuke Ishizawa :
Drug repositioning research aimed at improving the survival rate of patients with cardiopulmonary arrest using large-scale medical claims database,
ASHPMidyear2017Clinical Meeting&Exhibition, Dec. 2017.
11. Yuya Horinouchi, Yasumasa Ikeda, Hirofumi Hamano, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Kenshi Takechi, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The effect of iron on skeletal muscle atrophy in chronic kidney disease.,
Free Radical Biology and Medicine, Vol.112, No.1, 204-205, Dec. 2017.
(DOI: 10.1016/j.freeradbiomed.2017.10.323)
12. hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Indoxyl Sulfate Disturbs Normal Iron Metabolism via Hepcidin Upregulation in Chronic Kidney Disease,
ASN Kidney Week 2017 Annual Meeting, Nov. 2017.
13. Yuya Horinouchi, Yasumasa Ikeda, Masaki Imanishi, Yoshito Zamami, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Direct activated factor X inhibitor attenuates renal fibrosis on unilateral ureteral obstruction-induced nephrotoxicity.,
53rd Congress of the European Societies of Toxicology (eurotox2017), Sep. 2017.
14. Yuya Horinouchi, Yasumasa Ikeda, Masaki Imanishi, Yoshito Zamami, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
FACTOR XA INHIBITOR ATTENUATES RENAL INTERSTITIAL FIBROSIS IN MICE WITH UNILATERAL URETERAL OBSTRUCTION,
THE 13TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS(EACPT2017), Jun. 2017.
15. Yuki Izawa-Ishizawa, Keisuke Ishizawa, 田淵 正樹, Masaki Imanishi, Mai Takata, Eriko Sairyo, Yoshito Zamami, Yuya Horinouchi, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
NITROSONIFEDIPINE, A NOVEL ANTIOXIDANT, AMELIORATES NEUROLOGICALSYMPTOMS AND PROLONGS THE SURVIVAL IN A MALIGNANT STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS,
27th European Meeting on Hypertension and Cardiovascular Protection, Jun. 2017.
16. Masaki Imanishi, Kyohei Tanaka, Raiki Ikutoh, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
THE EFFECTS OF FEBUXOSTAT ON ANGIOTENSIN II-INDUCED VASCULAR REMODELING,
27th European Meeting on Hypertension and Cardiovascular Protection, Jun. 2017.
17. Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa and Toshiaki Tamaki :
IRON RESTRICTION PREVENTS RENAL TUBULOINTERSTITIAL INJURY INDUCED BY ALBUMIN OVERLOAD IN MICE,
54th ERA-EDTA Congress, Madrid, Jun. 2017.
18. Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa and Toshiaki Tamaki :
DIRECT FACTOR XA INHIBITOR PREVENTS RENAL INTERSTITIAL FIBROSIS IN MICE WITH UNILATERAL URETERAL OBSTRUCTION,
54th ERA-EDTA Congress, Madrid, Jun. 2017.
19. Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Indoxyl Sulfate Involves Abnormality of Iron Metabolism through Hepcidin Regulation,
Experimental Bioogy 2017, Chicago, Apr. 2017.
20. Ota Kazuma, Yoshitaka Kihira, Kishibuchi Reina, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda and Toshiaki Tamaki :
Disruption of hypoxia-inducible factor-1a deteriorates renal ischemia-reperfusion injury through dysregulation of Kv2.2-induced apoptosis in tubules.,
ASN KIDNEY WEEK 2016, Chicago, Nov. 2016.
21. Yoshito Zamami, Mitsui Marin, Moriguchi Hiroshi, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Kawasaki Hiromu, Toshiaki Tamaki and Keisuke Ishizawa :
Search for a preventative therapy for Bevacizumab-induced hypertension using the drug repositioning approach,
7th Scientific Meeting of Asian Society for Vascular Biology, Oct. 2016.
22. Yutaka Fukunaga, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Ichiro Hashimoto :
Topical Application of Nitrosonifedipine, a Novel Free Radical Scavenger, Ameliorate the Ischemic Skin Flap Necrosis,
Plastic Surgery THE MEETING 2016, Los Angeles, Sep. 2016.
23. Yuki Izawa-Ishizawa, Masaki Imanishi, Yuya Horinouchi, Kenshi Takechi, Yoshito Zamami, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
The effects of pitavastatin, a lipid-lowering agent, against aortic dissection model mice induced by L-NAME, a nitric oxide synthase inhibitor.,
The 9th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide/16th Annual Scientific Meeting of the Nitric Oxide Society of Japan., May 2016.
24. Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa and Toshiaki Tamaki :
The new insight of iron on tissue damage in metabolic disorders.,
The 9th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide/16th Annual Scientific Meeting of the Nitric Oxide Society of Japan., May 2016.
25. Yasumasa Ikeda, Keisuke Oshima, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The Involvement of Iron Supplementation on Erythropoietin Expression,
Experimental Biology 2016, Apr. 2016.
26. Yasumasa Ikeda, Hamano Hirofumi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Bilirubin Enhances Ischimia-induced Angiogenesis Through Akt-eNOS-Dependent Signaling Pathway,
American Heart Association Scientific Sessions 2015, Orlando, Nov. 2015.
27. Yuki Izawa-Ishizawa, Keisuke Ishizawa, Toya Hiroki, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Novel aortic dissection model by pharmacologically-induced endothelial dysfunction,
17th International Congress on Atherosclerosis 2015, Amsterdam, May 2015.
28. Yasumasa Ikeda, Yusuke Kanai, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The Effects of Bilirubin on Angiogenesis in Mice with Hindlimb Ischemia,
Experimental Biology 2015, Boston, Mar. 2015.
29. Keisuke Ishizawa, Kohara Yusuke, Sakurada Takumi, Toya Hiroki, Iki Yutaka, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine ameliorates the progression of aortic aneurysms by exerting antioxidative effects,
ESC Congress 2014, Barcelona, Sep. 2014.
30. Yasumasa Ikeda, Soichiro Tajima, Mizuki Imao, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Ferritin induces IL-1 production through inflammasome activation via NF-B-dependent manner in macrophages,
Experimental Biology 2014, San Diego, Apr. 2014.
31. Nhat-Tu Le, Yuichiro Takei, Yuki Izawa-Ishizawa, Kyung-Sun Heo, Hakjoo Lee, Alan V. Smrcka, Benjamin Miller, Kyung Ae Ko, Craig Morrell, Keigi Fujiwara, Masashi Akaike and Jun-ichi Abe :
A HMG-CoA Reductase Inhibitor (statin) Directly Activates Endothelial Erk5 And Prevents Endothelial Dysfunction And Acute Cardiac Allograft Rejection,
AHA scientific sessions 2013, Nov. 2013.
32. Keisuke Ishizawa, Noriko Yamano, Hiroyuki Kobori, Maki Urushihara, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine prevents the progression of diabetic nephropathy via attenuating the expression of intrarenal angiotensinogen and oxidative stress,
High Blood Pressure Research 2013 Scientific Sessions, Sep. 2013.
33. Yuki Izawa-Ishizawa, Keisuke Ishizawa, Sakiko Doi, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Rho-kinase is involved in inorganic phosphate-induced ERK1/2 activation in vascular smooth muscle cells,
World Biotechnology Congress 2013, Jun. 2013.
34. Yasumasa Ikeda, Hideaki Enomoto, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
The effect of dietary iron restriction against diabetic nephropathy in db/db mice,
Experimental Biology 2013, Apr. 2013.
35. Yusaku Maeda, Shuhei Tomita, Masaki Murakami, Hirotsugu Kurobe, Masaki Imanishi, Yasushi Yoshida, Yoichiro Hirata, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Tetsuya Kitagawa, Masataka Sata and Toshiaki Tamaki :
Deficiency of Hypoxia Inducible Factor-1a in SM-22a-Expressing Bone Marrow-Derived Cells Alleviates Neointimal Formation Following Wire-induced Vascular Formation,
American Heart Association Scientific Sessions 2012, Nov. 2012.
36. Yasumasa Ikeda, Hideaki Enomoto, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron Restriction Prevents the Progression of Diabetic Nephropathy in db/db Mice,
American Heart Association Scientific Sessions 2012, Nov. 2012.
37. Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia-inducible Factor-1a in Vascular Smooth Muscle Cells Regulates Angiotensin -induced Vascular Remodeling and AT1 Receptor Expression in Mouse Aortic Media,
American Heart Association Scientific Sessions 2012, Nov. 2012.
38. Hideaki Enomoto, Yasumasa Ikeda, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Protective Effects of Iron-Restricted Food against Diabetic Nephropathy in db/db Mice,
American Heart Association High Blood Pressure Research 2012, Sep. 2012.
39. Shoko Fujii, Keisuke Ishizawa, Takumi Sakurada, Noriko Yamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Asami Nuno, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine, a Photodegradation Product of Nifedipine, Prevents the Progression of Diabetic Nephropathy in Type II Diabetic Mice,
American Heart Association High Blood Pressure Research 2012, Sep. 2012.
40. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-inducible factor-1a deficiency in smooth muscle cell attenuates angiotensin -induced vascular remodeling in mice,
ISOTT (International Society on Oxygen Transport to Tissue) 2012, Aug. 2012.
41. Takumi Sakurada, Keisuke Ishizawa, Shoko Fujii, Yuki Izawa-Ishizawa, Masaki Imanishi, Asami Nuno, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Effects of nitrosonifedipine, a photodegradation product of nifedipine, on diabetic nephropathy in type II diabetic mice,
Experimental Biology 2012, Apr. 2012.
42. Yasumasa Ikeda, Hideaki Enomoto, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron restriction prevents progression of diabetic nephropathy,
KEYSTONE SYMPOSIA 40th ANNIVERSARY 1972-2012 Complications of Diabetes: Mechanisms of Injury and Failure of Repair, Mar. 2012.
43. Yusaku Maeda, Shuhei Tomita, Masaki Murakami, Hirotsugu Kurobe, Masaki Imanishi, Yasushi Yoshida, Yoichiro Hirata, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Tetsuya Kitagawa, Masataka Sata and Toshiaki Tamaki :
Deficiency of Hypoxia Inducible Factor-1 in SM-22-Expressing Bone Marrow-Derived Cells Alleviates Neointimal Formation Following Wire-induced Vascular Formation,
AHA SCIENTIFIC SESSIONS 2012, 2012.
44. Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia-inducible Factor-1 in Vascular Smooth Muscle Cells Regulates Angiotensin -induced Vascular Remodeling and AT1 Receptor Expression in Mouse Aortic Media,
AHA SCIENTIFIC SESSIONS 2012, 2012.
45. Fujii Shoko, Keisuke Ishizawa, Takumi Sakurada, Noriko Yamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Asami Nuno, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine, a Photodegradation Product of Nifedipine, Prevents the Progression of Diabetic Nephropathy in Type II Diabetic Mice,
HIGH BLOOD PRESSURE RESEARCH 2012 SCIENTIFIC SESSIONS, 2012.
46. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-inducible factor-1 deficiency in smooth muscle cell attenuates angiotensin II-induced vascular remodeling in mice,
The International Society on Oxygen Transport to Tissue 2012, 2012.
47. Takumi Sakurada, Keisuke Ishizawa, Shoko Fujii, Yuki Izawa-Ishizawa, Masaki Imanishi, Asami Nuno, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Effects of nitrosonifedipine, a photodegradation product of nifedipine, on diabetic nephropathy in type II diabetic mice,
Experimental Biology 2012, 2012.
48. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Smooth Muscle Cell-Specific Hypoxia-Inducible Factor-1a Deficiency Attenuates Angiotensin II-Induced Vascular Remodeling in Mice,
AHA scientific sessions 2011, Orlando, Nov. 2011.
49. Soichiro Tajima, Yasumasa Ikeda, Noriko Yamano, Koichiro Tsuchiya, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
Inhibition of Adipocyte Hypertrophy by Deferoxiamine Diabetic KKAy mice,
High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions, Orlando, Sep. 2011.
50. Kazuyuki Yamaguchi, Yoshitaka Kihira, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
Glucose Metabolism of Adipocytes is Regulated by Basic Fibroblast Growth Factor via Hypoxia-inducible Factor-1a,
High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions, Orlando, Sep. 2011.
51. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-inducible Factor-1a Deficiency in Smooth Muscle Cells Suppresses Angiotensin -induced Vascular Remodeling in Mice,
High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions, Orlando, Sep. 2011.
52. Yasumasa Ikeda, Ken-ichi Aihara, Sumiko Yoshida, Yoshitaka Kihira, Keisuke Ishizawa, Yuki Izawa-Ishizawa, Shuhei Tomita, Masataka Sata, Masashi Akaike, Shigeki Kato, Toshio Matsumoto and Toshiaki Tamaki :
Heparin Cofactor Promotes Angiogenesis via an AMPK-eNOS Signaling Pathway,
High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions, Orlando, Sep. 2011.
53. Yuki Izawa-Ishizawa, Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin -induced Vascular Remodeling is Improved by Nitrosonifedipine, a Possible New Class Drug Against Oxidative Stress,
High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions, Orlando, Sep. 2011.
54. Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitorosonifedipine is a new class drug to improves angiotensin II-induced vascular remodeling,
European Society of Cardiology Congress 2011, Aug. 2011.
55. Shuhei Tomita, Yoshitaka Kihira, Noriko Yamano, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Characterization on mice lacking HIF1a gene in renal ischemia-reperfusion injury,
ISOTT (International Society on Oxygen Transport to Tissue) 2011, Washington, D.C., Jul. 2011.
56. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Smooth Muscle Cell-specific Hypoxia-inducible Factor-1a Deficiency Attenuates Angiotensin II-induced Vascular Remodeling In Mice,
AHA SCIENTIFIC SESSIONS 2011, 2011.
57. Yuki Izawa-Ishizawa, Keisuke Ishizawa, Sakurada Takumi, Masaki Imanishi, Fujii Shoko, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Angiotensin II-induced Vascular Remodeling Is Improved By Nitrosonifedipine, A Possible New Class Drug,
HIGH BLOOD PRESSURE RESEARCH 2011 SCIENTIFIC SESSIONS, 2011.
58. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-inducible Factor-1 Deficiency In Smooth Muscle Cells Suppresses Angiotensin II-induced Vascular Remodeling In Mice,
HIGH BLOOD PRESSURE RESEARCH 2011 SCIENTIFIC SESSIONS, 2011.
59. Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitorosonifedipine is a new class drug to improve angiotensin II-induced vascular remodeling,
ESC Congress 2011, 2011.
60. Keisuke Ishizawa, Masaki Imanishi, Yuya Horinouchi, Yayoi Fukuhara, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Yoshitaka Kihira, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitroso-nifedipine is a new class drug to protect endothelial function for overcoming organ damage,
International Society of Hypertension 2010, Vancouver, Sep. 2010.
61. Hirotsugu Kurobe, M Urata, Yuki Izawa, Y Fukuhara, Tamotsu Kanbara, K Aihara, F Gonzalez and T Matsumoto :
Hif-1α In T Cells Pathway Plays A Crucial Role In The Progression Of Arteriosclerosis And Artery Intimal Thickening,
Scientific Sessions 2007, Florida, Nov. 2007.
62. Keisuke Ishizawa, Narantungalag Dorjsuren, Yuki Izawa-Ishizawa, Teppei Tsuneishi, Yuki Motobayashi, Hideki Ohnishi, Kunihisa Yamaguchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Inhibitory effects of olmesartan on TNF-α-induced cytotoxicity in human glomerular endothelial cells,
40th ASN annual meeting, San Francisco, Nov. 2007.
63. Hirotsugu Kurobe, M Urata, Yuki Izawa, Y Fukuhara, Tamotsu Kanbara, K Aikhara, T Tamaki, T Matsumoto, Tetsuya Kitagawa, M Yoshizumi and S Tomita :
HIF-1 signaling pathway plays a crucial role in the progression of atherosclerosis,
The 76th Congress of the European Atherosclerosis Society, Helsinki, Jun. 2007.
64. Hiroyuki Sakakibara, Yuki Izawa, Jun-ichiro Nakajima, Shujiro Seo, Toshiaki Tamaki, Yoshichika Kawai and Junji Terao :
Antidepressant effects of polyphenol rich herbal medicine, Ginkgo biloba, extracts in behavioral models,
232 nd American Chemical Society Meeting & Exposition, San Francisco, Sep. 2006.
65. Hirotsugu Kurobe, Yuki Izawa, Y Fukuhara, Tamotsu Kanbara, A Kurushima, Ken-ichi Aihara, Masashi Akaike, Masashi Kano, Takashi Kitaichi, Yutaka Masuda, Hiroyuki Azuma, Toshiaki Tamaki, Toshio Matsumoto, Tetsuya Kitagawa, Shuhei Tomita and Masanori Yoshizumi :
HIF-ARNT transcriptional system in Tcells has a pivotal role in vascular inflammation and remodeling,
XIL International Symposium on Atherosclerosis, Italy, Jun. 2006.
66. Hirotsugu Kurobe, Yuki Izawa, Yayoi Fukuhara, Tamotsu Kanbara, Ken-ichi Aihara, Masashi Akaike, Hiroyuki Azuma, Tetsuya Kitagawa, Toshiaki Tamaki, Toshio Matsumoto, Masaki Ueno, Shuhei Tomita and Masanori Yoshizumi :
T Cell-specific HIF-1α-deficient Mice, but Not ARNT-deficient Mice, Exhibit Exacerbated Inflammation and Vascular Remodeling in Response to Cuff Injury,
American Heart Association 2005 Scientifc Sessions, Dallas, Nov. 2005.
67. Toshiaki Tamaki, Yasuhisa Kanematsu, Yuki Izawa, Hideki Ohnishi, Yuki Motobayashi, Shoji Kagami and Koichiro Tsuchiya :
Chronic oral administration of nitrite restores circulating NO level and improves renal injury in L-NAME treated rats,
38th ASN annual meeting, Philadelphia, Nov. 2005.
68. Keisuke Ishizawa, Rika Sugimoto, Yuki Izawa, Koichiro Tsuchiya, Kazuo Minakuchi and Toshiaki Tamaki :
The inhibitory effect of adiponectin on migration and proliferation induced by PDGF in rat mesangial cells,
38th ASN annual meeting, Philadelphia, Nov. 2005.
69. Hiroyuki Sakakibara, Kaori Ishida, Yuki Izawa, Yuko Minami, Satomi Saito, Yoshichika Kawai, Butterweck Veronika, Toshiaki Tamaki, Yutaka Nakaya and Junji Terao :
Effects of Ginkgo biloba Extract on Rat brain Function,
2nd International Conference on Polyphenols and Health, California Davis, Davis, Oct. 2005.
70. Hiroyuki Sakakibara, Kaori Ishida, Yuki Izawa, Yuko Minami, Saito Saromi, Yoshichika Kawai, Butterweck Veronika, Toshiaki Tamaki, Yutaka Nakaya and Junji Terao :
Effects of forced swimming stress on rat brain function,
2005 COE International Conference ''Biological Mechanism for Stress Control'', Tokushima, Aug. 2005.
71. Keisuke Ishizawa, Rika Sugimoto, Yuki Izawa, Kazuo Minakuchi, Koichiro Tsuchiya and Toshiaki Tamaki :
Adiponectin inhibits PDGF-induced migration and proliferation in rat mesangial cells,
第10回アディポサイエンス研究会シンポジウム(第10回記念国際シンポジウム), Osaka, Aug. 2005.
72. Toshiaki Tamaki, Masumi Okamoto, Yasuhisa Kanematsu, Yuki Izawa, Shoji Kagami, Shuji Kondo, Masanori Yoshizumi and Koichiro Tsuchiya :
Dietary dose of nitrite attenuates L-NAME-induced renal injury in rats,
3rd World Congress of Nephrology, Singapore, Jun. 2005.
73. Masanori Yoshizumi, Keisuke Ishizawa, Yuki Izawa, Chieko Miki, Yoshiko Fujita, Yasuhisa Kanematsu, Koichiro Tsuchiya and Toshiaki Tamaki :
Aldosterone stimulates vascular smooth muscle cell proliferation through big mitogen-activated protein kinase1 activation,
16th scientific meeting of the interamerican society of hypertension, Cancun, Mexico, Apr. 2005.
74. Toshiaki Tamaki, Masumi Okamoto, Yasuhisa Kanematsu, Yuki Izawa, Shoji Kagami, Shuji Kondo, Maki Shimizu, Masanori Yoshizumi and Koichiro Tsuchiya :
Nitrite-derived nitric oxide formation following ischemia-reperfusion injury in rat kidney,
37th ASN annual meeting, St. Louis, MO, Oct. 2004.

Proceeding of Domestic Conference:

1. Masaya Kanda, Mitsuhiro Goda, Toshihiko Yoshioka, Ami Yoshida, Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Kenta Yagi, Hirofumi Hamano, Naoto Okada and Keisuke Ishizawa :
シスプラチン誘発急性腎障害に対する各種5-HT3受容体拮抗薬併用の影響,
第94回日本薬理学会年会, Mar. 2021.
2. Fuka Aizawa, Yoshito Zamami, Takahiro Niimura, Takehiro Kawashiri, Mitsuhiro Goda, Kenta Yagi, Yuki Izawa-Ishizawa and Keisuke Ishizawa :
HMG-CoA還元酵素阻害剤はGSTを介してオキサリプラチン誘発末梢神経障害を抑制する,
第94回日本薬理学会年会, Mar. 2021.
3. Yuki Izawa-Ishizawa, Miho Mitsunari, Yoshimi Bando, Satsuki Sumitani, Akira Tangoku and Mari Haku :
研究に関する男女共同参画・ダイバーシティの推進状況に関するアンケート調査 -全国の集計結果との比較から見える徳島大学の現状-,
第262回 徳島医学会学術集会(令和2年度冬期), Mar. 2021.
4. Keisuke Ishizawa, Mitsuhiro Goda, Masayuki Chuma, Kenta Yagi, Yuki Izawa-Ishizawa and Yoshito Zamami :
有害事象自発報告データベースを活用した抗がん剤副作用に対する予防法の探索,
第41回日本臨床薬理学会学術総会 学術委員会企画シンポジウム5, Dec. 2020.
5. Fuka Aizawa, Mitsuhiro Goda, Masaya Kanda, Toshihiko Yoshioka, Ami Yoshida, Takahiro Niimura, Kenta Yagi, Hirofumi Hamano, Naoto Okada, Yoshito Zamami, Yuki Izawa-Ishizawa and Keisuke Ishizawa :
シスプラチンと5-HT3受容体拮抗薬併用が腎機能障害に与える影響,
第30回日本循環薬理学会, Nov. 2020.
6. Yuki Izawa-Ishizawa, Yoshito Zamami, Niimura Takahiro, Mitsuhiro Goda, Kenta Yagi, Masayuki Chuma, Masaki Imanishi and Keisuke Ishizawa :
New strategy for Cardio-Oncology study; the combination of big data analysis and basic research,
第79回日本癌学会学術集会 シンポジウム8, Oct. 2020.
7. Masateru Kondoh, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Kotoko Suzuki, Rie Matsuoka, Yoshito Zamami, Masayuki Chuma, Yasumasa Ikeda and Keisuke Ishizawa :
薬剤誘発性急性大動脈疾患に対するケルセチンの抑制効果,
第137回日本薬理学会近畿部会, Jun. 2020.
8. Tatsuya Tsuda, Mitsuhiro Goda, Yuya Horinouchi, Yoshito Zamami, Yasumasa Ikeda, Keisuke Ishizawa, Ichiro Hashimoto and Yuki Izawa-Ishizawa :
血管平滑筋細胞石灰化シグナルにおけるRhoキナーゼーサイクロフィリンA経路の関与,
第260回 徳島医学会学術集会(令和元年度冬期), Feb. 2020.
9. Mitsuhiro Goda, Masaya Kanda, 前川 晃子, Takahiro Niimura, Yuki Izawa-Ishizawa, Yoshito Zamami, Masayuki Chuma, Kenshi Takechi, Hirofumi Hamano, Naoto Okada, Yuya Horinouchi, Yasumasa Ikeda, Hiroaki Yanagawa and Keisuke Ishizawa :
大規模医療情報データベースを活用したシスプラチン誘発腎障害に対する新規予防薬の探索とその有効性の検証,
第40回日本臨床薬理学会学術総会, Dec. 2019.
10. Takahiro Niimura, Yoshito Zamami, Yutaroh Naitoh, 川尻 雄大, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda and Keisuke Ishizawa :
抗がん剤誘発末梢神経障害の予防薬開発を目的とした医療ビッグデータ解析および基礎研究,
第40回日本臨床薬理学会学術総会, Dec. 2019.
11. Yoshito Zamami, Takahiro Niimura, 川尻 雄大, Mitsuhiro Goda, 相澤 風花, Naoto Okada, 濱野 裕章, Kenshi Takechi, Masayuki Chuma, Yuki Izawa-Ishizawa, Hiroaki Yanagawa and Keisuke Ishizawa :
大規模医療情報を活用した多施設共同臨床研究の提案,
第3回臨床薬理学集中講座フォローアップ・セミナー, Dec. 2019.
12. Tatsuya Tsuda, Yuki Izawa-Ishizawa, Yoshiro Abe and Ichiro Hashimoto :
血管内皮細胞特異的ERK5欠損の皮弁生着に対する影響の検討,
第28回 日本形成外科学会基礎学術集会, Nov. 2019.
13. Yuki Izawa-Ishizawa :
男女がともに活躍できる徳島大学を目指すAWAサポートセンターの取組み,
日本医療薬学会第29回年会, Nov. 2019.
14. Mitsuhiro Goda, 神田 将哉, 前川 晃子, Ami Yoshida, Takahiro Niimura, Yuki Izawa-Ishizawa, Yoshito Zamami, Masayuki Chuma, Kenshi Takechi, Yasumasa Ikeda and Keisuke Ishizawa :
ドラッグリポジショニング手法を用いたシスプラチン誘発腎障害に対する新規予防薬探索,
第29回日本循環薬理学会・第55回高血圧関連疾患モデル学会 合同学術集会, Nov. 2019.
15. Takahiro Niimura, Yoshito Zamami, Hiroumi Saito, 神田 将哉, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda and Keisuke Ishizawa :
大規模医療情報を活用した抗がん剤誘発心筋症予防薬の探索,
第29回日本循環薬理学会・第55回高血圧関連疾患モデル学会 合同学術集会, Nov. 2019.
16. 鈴木 琴子, Yuki Izawa-Ishizawa, Mitsuhiro Goda, 近藤 正輝, Masaki Imanishi, Yoshito Zamami, Yuya Horinouchi, Kenshi Takechi, Masayuki Chuma, Yasumasa Ikeda and Keisuke Ishizawa :
ケルセチンによる薬剤誘発性急性大動脈疾患発症抑制効果の検討,
第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2019.
17. Hiroumi Saito, Takahiro Niimura, Yoshito Zamami, Masaya Kanda, Mitsuhiro Goda, Yuki Izawa-Ishizawa, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yasumasa Ikeda and Keisuke Ishizawa :
大規模医療情報データベースを活用したドキソルビシン誘発心筋炎に対する予防薬の探索,
第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2019.
18. Hiroumi Saito, Takahiro Niimura, Yoshito Zamami, Masaya Kanda, Mitsuhiro Goda, Yuki Izawa-Ishizawa, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yasumasa Ikeda and Keisuke Ishizawa :
大規模医療情報データベースを活用したドキソルビシン誘発心筋炎に対する予防薬の探索,
第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2019.
19. 内藤 優太朗, Yoshito Zamami, Takahiro Niimura, 川尻 雄大, 相澤 風花, Shiori Nishiuchi, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, 島添 隆雄, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda and Keisuke Ishizawa :
大規模医療情報データベースを活用したオキサリプラチン誘発末梢神経障害に対する予防薬探索,
第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2019.
20. JOHZUKURI Natsumi, Shimon Takahashi, Kenshi Takechi, Masayuki Chuma, Mitsuhiro Goda, Yoshito Zamami, Yuki Izawa-Ishizawa, Yuya Horinouchi, Hirofumi Hamano, Naoto Okada, Kenshi Takechi, Yuya Horinouchi, Yasumasa Ikeda and Keisuke Ishizawa :
ドラッグリポジショニングによる大規模医療情報データベースを用いた新規抗てんかん薬の探索研究,
第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2019.
21. 村井 陽一, Mitsuhiro Goda, 神田 将哉, Takahiro Niimura, Ami Yoshida, Yuki Izawa-Ishizawa, Yoshito Zamami, Masayuki Chuma, Hirofumi Hamano, Naoto Okada, Kenshi Takechi, Yuya Horinouchi, Yasumasa Ikeda and Keisuke Ishizawa :
シスプラチンと各種5-HT3受容体拮抗薬の併用による腎機能への影響,
第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2019.
22. Masaya Kanda, Mitsuhiro Goda, Akiko Maegawa, Takahiro Niimura, Ami Yoshida, Yuki Izawa-Ishizawa, Yoshito Zamami, Masayuki Chuma, Kenshi Takechi, Hirofumi Hamano, 岡田 直人, 桐野 靖, 中村 敏己, Kazuhiko Teraoka and Keisuke Ishizawa :
ドラッグリポジショニング手法を用いたシスプラチン誘発腎障害の予防薬探索,
第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2019.
23. 相澤 風花, Yoshito Zamami, 内藤 優太郎, Takahiro Niimura, 川尻 雄大, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Yuki Izawa-Ishizawa, 小林 大介, 島添 隆雄, 桐野 靖, 中村 敏己, Kazuhiko Teraoka and Keisuke Ishizawa :
オキサリプラチン誘発末梢神経障害に対する新規予防薬の有効性に関する基礎的検証,
第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2019.
24. Masaya Kanda, Mitsuhiro Goda, Takahiro Niimura, Yuki Izawa-Ishizawa, Yoshito Zamami, Masayuki Chuma, Hirofumi Hamano, Naoto Okada, Kenshi Takechi, Yuya Horinouchi, Yasumasa Ikeda, 桐野 靖, 中村 敏己, Kazuhiko Teraoka and Keisuke Ishizawa :
シスプラチン誘発腎障害に対する各種 5-HT3 受容体拮抗薬の影響,
第29回日本医療薬学会年会, Nov. 2019.
25. 定作 奈津美, Shimon Takahashi, Kenshi Takechi, Masayuki Chuma, Mitsuhiro Goda, Yoshito Zamami, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda, Koichiro Tsuchiya and Keisuke Ishizawa :
ビッグデータを活用した新規抗てんかん薬の検討,
第29回日本医療薬学会年会, Nov. 2019.
26. Masayuki Chuma, Mitsuhiro Goda, Takahiro Niimura, Yoshito Zamami, Kenshi Takechi, Yuki Izawa-Ishizawa, 濱野 裕章, 石田 俊介, Takahiro Niimura, Masateru Kondoh, Takashi Bandoh, Naoto Okada, Keijo Fukushima, Hiromichi Fujino, Koichiro Tsuchiya, Yuya Horinouchi, Yasumasa Ikeda, Hiroaki Yanagawa and Keisuke Ishizawa :
ドラッグリポジショニング手法を用いたバンコマイシン関連腎障害の予防薬探索とその有用性の検討,
第13回日本腎臓病薬物療法学会学術集会・総会, Nov. 2019.
27. Yoshito Zamami, Yuki Izawa-Ishizawa, Takahiro Niimura, 小山 敏広, Hirofumi Hamano, Naoto Okada, Mitsuhiro Goda, Naoto Okada, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, 桐野 靖, 中村 敏己, Kazuhiko Teraoka and Keisuke Ishizawa :
大規模医療情報データベースを活用した周術期領域における薬剤疫学研究,
第29回日本医療薬学会年会 シンポジウム9, Nov. 2019.
28. Mitsuhiro Goda, Yoshito Zamami, Takahiro Niimura, Kenshi Takechi, Masayuki Chuma, 萱野 純史, Hirofumi Hamano, Naoto Okada, 島添 隆雄, Yuki Izawa-Ishizawa, 桐野 靖, 中村 敏己, Kazuhiko Teraoka and Keisuke Ishizawa :
大規模医療情報データベースを活用したオキサリプラチン誘発末梢神経障害に対する予防薬探索,
第29回日本医療薬学会年会 シンポジウム12, Nov. 2019.
29. Takahiro Niimura, Yoshito Zamami, Takahiro Niimura, Yutaroh Naitoh, 川尻 雄大, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda and Keisuke Ishizawa :
医療ビッグデータ解析と基礎研究を融合した抗がん剤誘発末梢神経障害の予防薬開発,
次世代を担う創薬・医療薬理シンポジウム2019, Aug. 2019.
30. Takahiro Niimura, Yoshito Zamami, Takahiro Niimura, 内藤 優太朗, 川尻 雄大, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda and Keisuke Ishizawa :
医療ビッグデータ解析と基礎研究を融合した抗がん剤誘発末梢神経障害の予防薬開発,
生体機能と創薬シンポジウム2019, Aug. 2019.
31. 齊藤 広海, Yoshito Zamami, Takahiro Niimura, Masaya Kanda, Mitsuhiro Goda, Yuki Izawa-Ishizawa, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yasumasa Ikeda and Keisuke Ishizawa :
大規模医療情報データベースを活用したドキソルビシン誘発心筋炎にたいする予防薬の探索,
第30回霧島神経薬理フォーラム, Aug. 2019.
32. 新村 貴博, Yoshito Zamami, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya and Keisuke Ishizawa :
大規模医療情報を用いたニコランジルの心肺停止後予後改善効果の検討,
医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム, Jul. 2019.
33. Yutaroh Naitoh, Takahiro Niimura, Yoshito Zamami, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda and Keisuke Ishizawa :
オキサリプラチン誘発末梢神経障害の予防薬探索を目的としたドラッグリポジショニング研究,
医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム, Jul. 2019.
34. 齊藤 広海, 新村 貴博, Yoshito Zamami, Masaya Kanda, Mitsuhiro Goda, Yuki Izawa-Ishizawa, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yasumasa Ikeda and Keisuke Ishizawa :
医療ビッグデータ解析を活用したドキソルビシン誘発心筋炎に対する予防薬探索研究,
医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム, Jul. 2019.
35. JOHZUKURI Natsumi, Shimon Takahashi, Kenshi Takechi, Masayuki Chuma, Mitsuhiro Goda, Yoshito Zamami, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda, Koichiro Tsuchiya and Keisuke Ishizawa :
大規模医療情報データベースを活用した新規抗てんかん薬の探索研究,
医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム, Jul. 2019.
36. Mitsuhiro Goda, 斉家 和仁, Akiko Maegawa, Masaya Kanda, Ami Yoshida, Yoichi Murai, Takahiro Niimura, Yuki Izawa-Ishizawa, Yoshito Zamami, Masayuki Chuma, Kenshi Takechi, Hirofumi Hamano, Naoto Okada, Keijo Fukushima, Hiromichi Fujino, Koichiro Tsuchiya, Yuya Horinouchi, Yasumasa Ikeda, Hiroaki Yanagawa and Keisuke Ishizawa :
医療ビッグデータを活用したシスプラチン誘発腎障害に対する新規予防薬の探索とその有効性の検証,
第4回中四国臨床薬理学会, Jul. 2019.
37. 新村 貴博, Yoshito Zamami, 川尻 雄大, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda and Keisuke Ishizawa :
ドラッグリポジショニング手法を用いたオキサリプラチン誘発末梢神経障害の予防薬探索,
第4回中四国臨床薬理学会, Jul. 2019.
38. Kotoko Suzuki, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Masateru Kondoh, Masaki Imanishi, Yoshito Zamami, Yuya Horinouchi, Kenshi Takechi, Masayuki Chuma, Yasumasa Ikeda and Keisuke Ishizawa :
薬剤誘発性急性大動脈疾患に対するケルセチンの効果,
第135回日本薬理学会近畿部会, Jun. 2019.
39. Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya and Keisuke Ishizawa :
医療ビッグデータ解析と基礎研究を融合した薬剤性副作用の機序解明および治療薬の開発,
第29回日本医療薬学会年会 シンポジウム13, Mar. 2019.
40. Kenshi Takechi, Masayuki Chuma, 石田 俊介, 坂東 寛, Yoshito Zamami, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda, Keisuke Ishizawa and Hiroaki Yanagawa :
向精神薬の副作用対策を基盤とした臨床研究とその活用,
第139回日本薬学会年会 一般シンポジウムS48, Mar. 2019.
41. Kenshi Takechi, Masayuki Chuma, 石田 俊介, 坂東 寛, Yoshito Zamami, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda, Keisuke Ishizawa and Hiroaki Yanagawa :
向精神薬の副作用対策を基盤とした臨床研究とその活用,
第139回日本薬学会年会 一般シンポジウムS48, Mar. 2019.
42. 近藤 正輝, Masaki Imanishi, Keijo Fukushima, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Yoshito Zamami, Kenshi Takechi, Masayuki Chuma, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya and Keisuke Ishizawa :
キサンチンオキシダーゼ阻害剤による新規血管線維化抑制機構の検討,
日本薬学会第139年会 大学院生シンポジウムGS03, Mar. 2019.
43. Yuya Horinouchi, Yasumasa Ikeda, Hirofumi Hamano, Masaki Imanishi, Keijo Fukushima, Mitsuhiro Goda, Kenshi Takechi, Licht Miyamoto, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎不全関連骨格筋萎縮における鉄代謝異常,
第92回日本薬理学会年会, Mar. 2019.
44. Yasumasa Ikeda, Akiho Satoh, Yuya Horinouchi, Yuki Izawa-Ishizawa, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron accumulation negatively regulates skeletal muscle myogenesis,
第92回日本薬理学会年会, Mar. 2019.
45. Mitsuhiro Goda, Masaya Kanda, Takahiro Niimura, Yuki Izawa-Ishizawa, Yoshito Zamami, Masayuki Chuma, 濱野 裕章, 生田 賢治, Naoto Okada, Kenshi Takechi, Yuya Horinouchi, Yasumasa Ikeda, Yasushi Kirino, 中村 敏己, Kazuhiko Teraoka and Keisuke Ishizawa :
ビッグデータを用いたシスプラチン誘発腎障害に対する新規予防薬の探索とその有効性の検証,
日本薬学会第139年会, Mar. 2019.
46. Mitsuhiro Goda, Masaya Kanda, Takahiro Niimura, Yuki Izawa-Ishizawa, Yoshito Zamami, Masayuki Chuma, 濱野 裕章, 生田 賢治, Naoto Okada, Kenshi Takechi, Yuya Horinouchi, Yasumasa Ikeda, Yasushi Kirino, 中村 敏己, Kazuhiko Teraoka and Keisuke Ishizawa :
シスプラチン誘発腎障害に対する新規予防薬の有効性の基礎的検証,
日本臨床腫瘍薬学会学術大会2019, Mar. 2019.
47. Mitsuhiro Goda, 神田 将哉, 新村 貴博, Yuki Izawa-Ishizawa, Yoshito Zamami, Masayuki Chuma, 濱野 裕章, 生田 賢治, Naoto Okada, Kenshi Takechi, Yuya Horinouchi, Yasumasa Ikeda and Keisuke Ishizawa :
シスプラチン誘発腎障害に対する新規予防薬の有効性の検証,
第92回日本薬理学会年会, Mar. 2019.
48. 鈴木 琴子, Yuki Izawa-Ishizawa, Masateru Kondoh, Masaki Imanishi, Yoshito Zamami, Yuya Horinouchi, Kenshi Takechi, Mitsuhiro Goda, Masayuki Chuma, Yasumasa Ikeda and Keisuke Ishizawa :
薬物誘発性大動脈瘤または大動脈解離モデルマウスに対するケルセチンの効果,
第92回日本薬理学会年会, Mar. 2019.
49. 新村 貴博, Yoshito Zamami, 川尻 雄大, Mitsuhiro Goda, Naoto Okada, 萱野 純史, 小山 敏広, Masaki Imanishi, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, 小林 大介, 島添 隆雄 and Keisuke Ishizawa :
ドラッグリポジショニング手法を用いたオキサリプラチン誘発末梢神経障害の予防薬探索,
第92回日本薬理学会年会 学生セッション, Mar. 2019.
50. Yoshito Zamami, Takahiro Niimura, 川尻 雄大, Mitsuhiro Goda, Naoto Okada, Hirofumi Hamano, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, 島添 隆雄 and Keisuke Ishizawa :
大規模医療情報データベースを活用した抗がん剤誘発副作用に対する予防薬の探索,
第92回日本薬理学会年会 年会企画シンポジウム, Mar. 2019.
51. Yuya Horinouchi, Yasumasa Ikeda, Hiroaki Watanabe, Hirofumi Hamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
マクロファージフェリチン欠損は肥満・糖尿病における脂肪炎症を抑制する,
第48回日本心脈管作動物質学会, Feb. 2019.
52. 藤本 望, 村田 梨菜, Keiji Murakami, Hideki Fujii, Licht Miyamoto, 井上 貴久, Koichiro Tsuchiya, Yasumasa Ikeda, Yuki Izawa-Ishizawa and Shuichi Hamano :
唾液中の硝酸イオンが口腔細菌に与える影響について·,
第42回徳島県医学検査学会, Dec. 2018.
53. Yuki Izawa-Ishizawa :
新規大動脈解離モデルマウスの開発と予防薬の探索,
第4回四国オープンイノベーションワークショップin徳島, Dec. 2018.
54. Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Hiroumi Saito, Masaki Imanishi, Kenshi Takechi, Masayuki Chuma, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya and Keisuke Ishizawa :
大規模医療情報データベースおよび遺伝子発現データベースを活用した薬剤性心筋炎に対する予防薬の探索,
第28回日本医療薬学会年会 シンポジウム, Nov. 2018.
55. Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Hirofumi Hamano, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Kenshi Takechi, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
リアルワールドビッグデータを活用した新規腎保護薬の探索,
第28回日本医療薬学会年会, Nov. 2018.
56. Yoshito Zamami, Yuki Izawa-Ishizawa, 新村 貴博, Masaki Imanishi, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Yasumasa Ikeda, 桐野 靖, 中村 敏己, Kazuhiko Teraoka and Keisuke Ishizawa :
救急・集中治療領域において大規模医療情報データベースを活用したトランスレーショナルリサーチ,
第29回霧島神経薬理フォーラム, Nov. 2018.
57. 桂 明里, Licht Miyamoto, 服部 真奈, 津田 勝範, 森崎 実友, Yuki Izawa-Ishizawa and Koichiro Tsuchiya :
青黛含有成分による細胞増殖活性の検討,
第134回日本薬理学会近畿部会, Nov. 2018.
58. Yuya Horinouchi, Yasumasa Ikeda, Hirofumi Hamano, Masaki Imanishi, Keijo Fukushima, Mitsuhiro Goda, Kenshi Takechi, Licht Miyamoto, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎不全関連サルコペニアにおける鉄の関与,
第134回日本薬理学会近畿部会, Nov. 2018.
59. 斉家 和仁, Mitsuhiro Goda, 伊勢 諒, 新村 貴博, Yuki Izawa-Ishizawa, Yoshito Zamami, Masayuki Chuma, Naoto Okada, Kenshi Takechi, Masaki Imanishi, Yasumasa Ikeda, 演野 裕章, Yuya Horinouchi, Koichiro Tsuchiya and Keisuke Ishizawa :
シスプラチン誘発腎障害に対する脂質異常症治療薬の影響,
第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2018.
60. 生藤 来希, Masaki Imanishi, 山川 祐介, Keijo Fukushima, 前川 晃子, Yuya Horinouchi, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Yoshito Zamami, Kenshi Takechi, Masayuki Chuma, Yasumasa Ikeda, Hiromichi Fujino and Koichiro Tsuchiya :
大腸がん増大におけるがん関連線維芽細胞由来ERKSの役割,
第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2018.
61. Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Yuki Izawa-Ishizawa, Hiromichi Fujino and Toshiaki Tamaki :
リアルワールドデータを活用した新規腎保護薬の探索,
第48回日本腎臓学会西部学術大会, Sep. 2018.
62. Yuya Horinouchi, Yasumasa Ikeda, Hiroaki Watanabe, Hirofumi Hamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Yoshito Zamami, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
マクロファージ鉄の肥満・糖尿病における役割 第42回日本鉄バイオサイエンス学会学術集会 2018/9/2 石川県 金沢医科大学病院北辰講堂,
第42回日本鉄バイオサイエンス学会学術集会, Sep. 2018.
63. 新村 貴博, Yoshito Zamami, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya and Keisuke Ishizawa :
大規模医療情報を活用した新規心肺蘇生後脳症治療薬の探索,
第29回霧島神経薬理フォーラム, Aug. 2018.
64. Yuki Izawa-Ishizawa, Yu Kagimoto, Masaki Imanishi, Yusuke Iwata, Kotoko Suzuki, Yuya Horinouchi, Kenshi Takechi, Yoshito Zamami, Yasumasa Ikeda, Keisuke Ishizawa and Toshiaki Tamaki :
第40回徳島医学会賞受賞講演 動脈硬化性疾患発症に対するケルセチンの効果,
第257回 徳島医学会学術集会(平成30年度夏季), Aug. 2018.
65. Yoshito Zamami, 新村 貴博, Yuki Izawa-Ishizawa, Kenshi Takechi, Masaki Imanishi, Masayuki Chuma, Yuya Horinouchi, Yasumasa Ikeda, Koichiro Tsuchiya and Keisuke Ishizawa :
医療情報データベースを活用した抗がん剤誘発副作用に対する予防薬の探索研究,
第21回日本医薬品情報学会総会・学術大会, Jul. 2018.
66. Masaki Imanishi, Masateru Kondoh, 山川 裕介, 生藤 来希, 村井 陽一, Yoshito Zamami, Kenshi Takechi, Masayuki Chuma, Yuya Horinouchi, Keijo Fukushima, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya and Keisuke Ishizawa :
Angiotensin II誘発性心臓線維化は線維芽細胞特異的ERK5欠損マウスにおいて亢進される,
第133回日本薬理学会近畿部会, Jun. 2018.
67. Yoshito Zamami, Marin Mitsui, Yuki Izawa-Ishizawa, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Keijo Fukushima, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを活用したベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究,
日本薬学会第138年会, Mar. 2018.
68. Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
ドラッグリポジショニング手法を用いた心肺蘇生後脳症治療薬の探索,
日本薬学会第138年会, Mar. 2018.
69. Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa and Toshiaki Tamaki :
Factor Xa Inhibitor Exerts a Protective Effect against Renal Injury,
第82回日本循環器学会学術集会, Mar. 2018.
70. Yoshito Zamami, Marin Mitsui, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, 桐野 靖, 中村 敏己, 寺岡 和彦 and Keisuke Ishizawa :
有害事象自発報告データベースを活用したベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究,
日本臨床腫瘍薬学会学術大会2018, Mar. 2018.
71. Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Hirofumi Hamano, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
大規模医療情報データベース解析と基礎研究の融合による新規腎保護薬の探索,
第256回 徳島医学会学術集会(平成29年度冬期), Feb. 2018.
72. Yuki Izawa-Ishizawa, Yu Kagimoto, Masaki Imanishi, Yusuke Iwata, Yuya Horinouchi, Kenshi Takechi, Yoshito Zamami, Yasumasa Ikeda, Keisuke Ishizawa and Toshiaki Tamaki :
マウス大動脈瘤形成に対するケルセチンの効果,
第256回 徳島医学会学術集会(平成29年度冬期), Feb. 2018.
73. Masaki Imanishi, Masateru Kondoh, Kyohei Tanaka, Raiki Ikutoh, Yoichi Murai, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
Febuxostatの尿酸合成抑制作用とは独立した血管線維化抑制機構の解明,
第256回 徳島医学会学術集会(平成29年度冬期), Feb. 2018.
74. Kenshi Takechi, Yoshito Zamami, Masaki Imanishi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Toshiaki Tamaki, Keisuke Ishizawa and Hiroaki Yanagawa :
てんかん誘発性精神症状の行動学的解析および治療薬の探索と作用機序の解明,
第256回 徳島医学会学術集会(平成29年度冬期), Feb. 2018.
75. Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
大規模医療情報を活用した心肺停止患者に対するニコランジルの有効性に関する検討,
第256回 徳島医学会学術集会(平成29年度冬期), Feb. 2018.
76. Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
第Xa因子阻害剤の腎保護効果,
第47回日本心脈管作動物質学会, Feb. 2018.
77. Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Yuki Izawa-Ishizawa, Hiromichi Fujino and Toshiaki Tamaki :
医療ビッグデータを活用した腎保護薬の探索,
2017年度 肥満・糖尿病クラスター・ミニリトリート, Feb. 2018.
78. Yuya Horinouchi, Yasumasa Ikeda, Keijo Fukushima, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, Hiromichi Fujino, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
第Xa因子阻害薬の腎保護効果,
第10回 心・血管クラスター・ミニリトリート, 2017.
79. Sakiko Hino, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Yuya Horinouchi, Yasumasa Ikeda, Toshiaki Tamaki and Keisuke Ishizawa :
大規模医療情報を活用した薬剤性腎障害に対する予防薬の探索,
西日本医学生学術フォーラム2017, Dec. 2017.
80. Yusuke Iwata, Yuki Izawa-Ishizawa, Yu Kagimoto, Kotoko Suzuki, Yuya Horinouchi, Yasumasa Ikeda, Keisuke Ishizawa and Toshiaki Tamaki :
マウス大動脈瘤形成に対するケルセチンの効果,
西日本医学生学術フォーラム2017, Dec. 2017.
81. Yuki Izawa-Ishizawa, Yu Kagimoto, Masaki Imanishi, Yuya Horinouchi, Kotoko Suzuki, Yusuke Iwata, Yoshito Zamami, Kenshi Takechi, Yasumasa Ikeda, Toshiaki Tamaki and Keisuke Ishizawa :
ケルセチンによる動脈硬化性疾患発症に対する予防効果の検討,
第27回日本循環薬理学会, Dec. 2017.
82. Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
大規模医療情報を用いて新規心肺蘇生後症候群治療薬の開発を志向したドラッグリポジショニング研究,
第38回日本臨床薬理学会学術総会, Dec. 2017.
83. Yoshito Zamami, Yuki Izawa-Ishizawa, Takahiro Niimura, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
臨床薬理学集中講座修了後の研究活動∼大規模医療情報を活用したドラッグリポジショニング研究を中心に∼,
第38回日本臨床薬理学会学術総会 臨床薬理学集中講座フォローアップ・セミナー, Dec. 2017.
84. Hiroaki Watanabe, Yasumasa Ikeda, Hirofumi Hamano, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
肥満・糖尿病におけるマクロファージ鉄制御機構の検討,
第132回日本薬理学会近畿部会, Nov. 2017.
85. Takahiro Niimura, Yoshito Zamami, 小山 敏広, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
ドラッグリポジショニングを切り口とした心肺蘇生後症候群治療薬の探索研究,
第27回日本医療薬学会年会, Nov. 2017.
86. Yoshito Zamami, 小山 敏広, Yuki Izawa-Ishizawa, Takahiro Niimura, Masaki Imanishi, Kenshi Takechi, Yuya Horinouchi, 桐野 靖, 中村 敏己, 寺岡 和彦, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
大規模医療情報を活用して心肺停止患者の生存率向上を志向したドラッグリポジショニング研究,
第27回日本医療薬学会年会, Nov. 2017.
87. Marin Mitsui, Yoshito Zamami, Yuki Izawa-Ishizawa, Takahiro Niimura, Kenshi Takechi, Masaki Imanishi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを基にしたベバシズマブと相互作用を起こす薬剤の探索研究,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
88. Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
心肺停止患者の予後に与えるニコランジルの影響-大規模レセプト情報を用いた検討,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
89. Shiori Urushizaki, Yoshito Zamami, Yuki Izawa-Ishizawa, Takahiro Niimura, Kenshi Takechi, Masaki Imanishi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
大規模医療情報を活用して新規心肺蘇生後症候群治療薬の開発を志向したドラッグリポジショニング研究,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
90. Yu Kagimoto, Yuki Izawa-Ishizawa, Mayuko Hosohka, Naoko Saito, Kotoko Suzuki, Masaki Imanishi, Yuya Horinouchi, Yoshito Zamami, Kenshi Takechi, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
急性大動脈解離易発症マウスにおけるquercetinの効果,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
91. Kyohei Tanaka, Masaki Imanishi, Masateru Kondoh, Raiki Ikutoh, Yoichi Murai, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
フェブキソスタットの尿酸合成抑制剤作用とは独立した血管線維化抑制作用の検討,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
92. Hiroaki Watanabe, Yasumasa Ikeda, Hirofumi Hamano, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
肥満・糖尿病におけるマクロファージ鉄の役割の検討,
第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Oct. 2017.
93. Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎臓病における尿毒素蓄積によるヘプシジン制御と鉄代謝破綻のメカニズムの解明,
第41回日本鉄バイオサイエンス学会学術集会, Sep. 2017.
94. Yasumasa Ikeda, Yuya Horinouchi, Hirofumi Hamano, 平山 祐, Seiji Kishi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Ken-ichi Aihara, Hideko Nagasawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄摂取制限による尿細管間質障害の抑制効果の検討,
第41回日本鉄バイオサイエンス学会学術集会, Sep. 2017.
95. Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎不全における尿毒素蓄積はヘプシジンを介した鉄代謝恒常性破綻に関与する,
大阪市大フォーラム, Aug. 2017.
96. Yoshito Zamami, Yuki Izawa-Ishizawa, 桐野 靖, Marin Mitsui, Shiori Urushizaki, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを切り口としたベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究,
医療薬学フォーラム2017 第25回クリニカルファーマシーシンポジウム, Aug. 2017.
97. Takahiro Niimura, Yoshito Zamami, Yuki Izawa-Ishizawa, Masaki Imanishi, Kenshi Takechi, Keijo Fukushima, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
心肺蘇生後症候群治療薬の開発を目的としたドラッグリポジショニング研究-大規模医療情報を活用した検討-,
第255回 徳島医学会学術集会, Aug. 2017.
98. Yoshito Zamami, Yuki Izawa-Ishizawa, 桐野 靖, Marin Mitsui, Shiori Urushizaki, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを切り口としたベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究,
医療薬学フォーラム2017 第25回クリニカルファーマシーシンポジウム, Jul. 2017.
99. Yuya Horinouchi, Yasumasa Ikeda, Masaki Imanishi, Yoshito Zamami, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
経口FXa阻害剤の腎線維化抑制効果,
医療薬学フォーラム2017 第25回クリニカルファーマシーシンポジウム, Jul. 2017.
100. Yuya Horinouchi, Yasumasa Ikeda, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
第Xa因子阻害剤は腎間質線維化を抑制する,
第131回 日本薬理学会近畿部会, Jun. 2017.
101. Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Kenshi Takechi, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
インドキシル硫酸蓄積はヘプシジン制御を介して鉄代謝恒常性破綻に関与する,
第131回 日本薬理学会近畿部会, Jun. 2017.
102. Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa and Toshiaki Tamaki :
Inhibitory effect of dietary iron restriction on albumin-induced renal tubulointerstitial injury,
第60回日本腎臓学会学術総会, May 2017.
103. Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
インドキシル硫酸はヘプシジンを介した鉄代謝異常に関与する,
第60回日本腎臓学会学術総会, May 2017.
104. Yuya Horinouchi, Yasumasa Ikeda, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
FXa阻害剤は腎間質線維化を抑制する,
第60回日本腎臓学会学術総会, May 2017.
105. Marin Mitsui, Yoshito Zamami, Yuki Izawa-Ishizawa, Shiori Urushizaki, 桐野 靖, Kazuhito Saike, Hiroshi Moriguchi, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを基にしたベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究,
日本薬学会 第137年会, Mar. 2017.
106. Yuya Horinouchi, Yasumasa Ikeda, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
FXa 阻害剤の片側尿管結紮モデルマウスにおける腎間質線維化抑制作用,
日本薬学会 第137年会, Mar. 2017.
107. Raiki Ikutoh, Masaki Imanishi, Kyohei Tanaka, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
アンジオテンシンII 誘発性血管リモデリングに対するキサンチンオキシダーゼ阻害剤の影響,
日本薬学会 第137年会, Mar. 2017.
108. Yuya Horinouchi, Yasumasa Ikeda, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Factor Xa inhibitor attenuates renal fibrosis in mice with unilateral ureteral obstruction,
第90回日本薬理学会年会, Mar. 2017.
109. Masaki Imanishi, Kyohei Tanaka, Raiki Ikuto, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
Febuxostat suppresses angiotensin II-induced aortic fibrosis,
第90回日本薬理学会年会, Mar. 2017.
110. Masaki Imanishi, 田中 恭平, 生藤 来希, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
フェブキソスタットはアンジオテンシンII誘発性大動脈繊維化を抑制する,
第90回日本薬理学会年会(長崎), Mar. 2017.
111. Yuki Izawa-Ishizawa, Mayuko Hosooka, Naoko Saito, Masaki Imanishi, Yuya Horinouchi, Yoshito Zamami, Kenshi Takechi, Yasumasa Ikeda, Koichiro Tsuchiya, Keisuke Ishizawa and Toshiaki Tamaki :
The effect of quercetin on the aortic dissection onset via its endothelial protective effect in mice,
第90回日本薬理学会年会, Mar. 2017.
112. Koichiro Tsuchiya, Yasumasa Ikeda, Yuki Izawa-Ishizawa, Yuya Horinouchi, Licht Miyamoto and Toshiaki Tamaki :
鉄ストレスと代謝性疾患-鉄ストレスによる疾患と,鉄ストレスによる治療,
日本薬学会第137年会, Mar. 2017.
113. Yoshito Zamami, Yuki Izawa-Ishizawa, 桐野 靖, 三井 茉綸, 漆崎 汐里, 斉家 和仁, 森口 浩史, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
有害事象自発報告データベースを切り口としたベバシズマブと相互作用を起こす薬剤の探索研究,
第46回日本心脈管作動物質学会年会, Feb. 2017.
114. Masaki Imanishi, 田中 恭平, 生藤 来希, Yoshito Zamami, Kenshi Takechi, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
Angiotensin II誘発性血管リモデリングに対するfebuxostatの効果,
第46回日本心脈管作動物質学会, Feb. 2017.
115. Hirofumi Hamano, Yasumasa Ikeda, Hiroaki Watanabe, Yuya Horinouchi, Akiho Satoh, Keisuke Oshima, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎不全における尿毒素蓄積が生体内鉄代謝に与える影響の検討,
第46回日本心脈管作動物質学会, Feb. 2017.
116. Yuki Izawa-Ishizawa, 細岡 真由子, 斎藤 尚子, 鍵本 優有, Masaki Imanishi, Yoshito Zamami, Yuya Horinouchi, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
ケルセチンによるマウス大動脈解離発症予防効果の検討,
第46回日本心脈管作動物質学会年会, Feb. 2017.
117. Yuki Izawa-Ishizawa, Yutaka Fukunaga, 西良 恵理子, Masaki Imanishi, Yuya Horinouchi, Yasumasa Ikeda, Yoshito Zamami, Kenshi Takechi, Keisuke Ishizawa, Koichiro Tsuchiya, Ichiro Hashimoto and Toshiaki Tamaki :
ニトロソニフェジピンは虚血性皮弁モデルにおいて皮弁壊死を抑制する,
第26回日本循環薬理学会, Dec. 2016.
118. 細岡 真由子, Yuki Izawa-Ishizawa, 斎藤 尚子, Masaki Imanishi, Yoshito Zamami, Licht Miyamoto, Yuya Horinouchi, Yasumasa Ikeda, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
Quercetin による血管内皮細胞保護効果の検討,
第130回日本薬理学会近畿部会, Nov. 2016.
119. Akiho Satoh, Yasumasa Ikeda, Hirofumi Hamano, Yuya Horinouchi, Mizuki Imao, Hiroaki Watanabe, Yuki Izawa-Ishizawa, Licht Miyamoto, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
鉄欠乏が骨格筋に与える作用の検討,
第55回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2016.
120. Yutaka Fukunaga, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Ichiro Hashimoto :
虚血性皮弁壊死モデルにおける抗酸化薬ニトロソニフェジピンの壊死抑制効果,
第25回日本形成外科学会基礎学術集会, Sep. 2016.
121. 三井 茉綸, Yoshito Zamami, 漆崎 汐里, 斉家 和仁, 森口 浩史, Kenshi Takechi, Masaki Imanishi, Yuya Horinouchi, Licht Miyamoto, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Hiromichi Fujino, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
ドラッグリポジショニングを切り口としたベバシズマブ誘発高血圧に対する予防薬の探索研究,
第27回霧島神経薬理フォーラム(福岡), Aug. 2016.
122. Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshito Zamami, 田淵 正樹, Toshiaki Tamaki and Keisuke Ishizawa :
脳卒中後の神経症状増悪に対するニトロソニフェジピンの効果,
第46回日本神経精神薬理学会年会( ソウル), Jul. 2016.
123. Yuki Izawa-Ishizawa, 細岡 真由子, 斎藤 尚子, Yuya Horinouchi, Masaki Imanishi, Yoshito Zamami, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
ケルセチン代謝産物Q3GAの血管内皮膚細胞に対する短期及び長期効果の検討,
第129回日薬理学会学会近畿部会( 広島), Jun. 2016.
124. Yasumasa Ikeda, 佐藤 明穂, Yuya Horinouchi, Yuki Izawa-Ishizawa, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
骨格筋分化における鉄の役割,
第129回日薬理学会学会近畿部会 (広島), Jun. 2016.
125. Yasumasa Ikeda, Keisuke Oshima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄は低酸素誘導因子を抑制してエリスロポエチン発現を低下させる,
第59回日本腎臓学会学術総会, Jun. 2016.
126. 細岡 真由子, Yuki Izawa-Ishizawa, 斎藤 尚子, Licht Miyamoto, Masaki Imanishi, Yoshito Zamami, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
ケルセチン生体内代謝産物 quercetin -3-O-β-Dglucuronideによる血管内皮細胞保護効果,
日本薬学会第136年会(横浜), Mar. 2016.
127. 鍵本 優有, Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshito Zamami, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
無機リン刺激による血管平滑筋細胞石灰化におけるrho-kinase 及び cyclophilinA の関与,
日本薬学会第136年会(横浜), Mar. 2016.
128. Hiroaki Watanabe, Yasumasa Ikeda, Hirofumi Hamano, Akiho Satoh, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
慢性腎臓病におけるヘプシジン制御メカニズムの検討,
日本薬学会第136年会(横浜), Mar. 2016.
129. 佐藤 明穂, Yasumasa Ikeda, Yuya Horinouchi, 濱野 裕章, 今尾 瑞季, 渡邉 大晃, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Toshiaki Tamaki, Licht Miyamoto and Koichiro Tsuchiya :
鉄過剰による骨格筋分化抑制作用の解明,
日本薬学会第136年会(横浜), Mar. 2016.
130. Yasumasa Ikeda, Keisuke Oshima, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Iron Supplementation Suppressed Erythropoietin Expression through HIF-dependent Pathway,
The 80th Annual Scientific Meeting of the Japanese Circulation Society, Mar. 2016.
131. 太田 和馬, Yoshitaka Kihira, 岸渕 麗奈, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
電位依存性カリウムチャネルKv2.2は腎虚血再灌流障害の軽減に関与する,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
132. 岸渕 麗奈, Yoshitaka Kihira, Kunihisa Yamaguchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
HIF-1aはアポトーシス制御因子Bcl-2及びCHAC1の発現制御を介して腎虚血再灌流障害からの回復に関与する,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
133. 斎藤 尚子, Yuki Izawa-Ishizawa, 細岡 真由子, Yoshitaka Kihira, Masaki Imanishi, Yoshito Zamami, Yasumasa Ikeda, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
ケルセチン代謝物Q3GAによる血管内皮細胞保護効果の検討,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
134. 青木 友里, Yuki Izawa-Ishizawa, 高田 真衣, 田渕 正樹, Masaki Imanishi, Yoshito Zamami, 福永 豊, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya, Keisuke Ishizawa and Toshiaki Tamaki :
神経突起伸長および脳卒中後神経症状に対するニトロソニフェジピンの効果,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
135. 大島 啓亮, Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄のエリスロポエチン発現への影響の検討,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
136. 佐藤 明穂, Yasumasa Ikeda, Yuya Horinouchi, 濱野 裕章, 今尾 瑞季, 渡邉 大晃, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄欠乏に伴う骨格筋萎縮メカニズム,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
137. 濱野 裕章, Yasumasa Ikeda, 渡邉 大晃, 佐藤 明穂, 大島 啓亮, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
尿毒素は慢性腎不全におけるヘプシジン発現に関与する,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
138. Yuki Izawa-Ishizawa, Masaki Imanishi, Yoshitaka Kihira, Licht Miyamoto, Yoshito Zamami, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Keisuke Ishizawa :
Development of endothelial dysfunction-induced aortic dissection model and search for a preventive strategy,
第89回 日本薬理学会年会(神奈川), Mar. 2016.
139. Masaki Imanishi, Keisuke Ishizawa, 小原 佑介, 櫻田 巧, 戸谷 紘基, 長尾 朋子, 壱岐 豊, 細岡 真由子, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニフェジピン光分解産物による血管リモデリング抑制効果,
第252回 徳島医学会学術集会(平成27年度冬期), Feb. 2016.
140. Keisuke Oshima, Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄のエリスロポエチン発現への影響の検討,
第45回日本心脈管作動物質学会, Feb. 2016.
141. Masaki Imanishi, Keisuke Ishizawa, 小原 佑介, 櫻田 巧, 戸谷 紘基, 長尾 朋子, 壱岐 豊, 細岡 真由子, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンによる抗大動脈瘤機序の検討,
第45回日本心脈管作動物質学会, Feb. 2016.
142. Yuki Izawa-Ishizawa, Keisuke Ishizawa, 鍵本 優有, 斎藤 尚子, 高田 真衣, Yoshitaka Kihira, Masaki Imanishi, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
高リン刺激は血管平滑筋細胞においてrho-kinase-cyclophilin A経路を活性化させる,
第45回日本心脈管作動物質学会, Feb. 2016.
143. Yasumasa Ikeda, 濱野 裕章, 渡邉 大晃, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎臓病におけるヘプシジン制御メカニズムの検討,
第25回日本循環薬理学会, Dec. 2015.
144. Yuki Izawa-Ishizawa, Keisuke Ishizawa, 高田 真衣, 田渕 正樹, Masaki Imanishi, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンは悪性脳卒中易発性高血圧自然発症ラットの 生命予後を改善する,
第25回日本循環薬理学会, Dec. 2015.
145. 斎藤 尚子, Yuki Izawa-Ishizawa, Keisuke Ishizawa, 戸谷 紘基, Masaki Imanishi, 鍵本 優有, 細岡 真由子, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
大動脈解離発症における内皮障害の関与,
第25回日本循環薬理学会, Dec. 2015.
146. Hirofumi Hamano, Yasumasa Ikeda, Yuya Horinouchi, Akiho Satoh, Hiroaki Watanabe, Keisuke Oshima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
慢性腎不全における尿毒素によるヘプシジン制御機構,
第128回日本薬理学会近畿部会, Nov. 2015.
147. 今尾 瑞季, Yasumasa Ikeda, 佐藤 明穂, 濱野 裕章, Yuya Horinouchi, Licht Miyamoto, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Toshiaki Tamaki and Koichiro Tsuchiya :
鉄蓄積によって引き起こされる骨格筋萎縮のメカニズム,
第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2015.
148. 高田 真衣, Keisuke Ishizawa, 田渕 正樹, Yuki Izawa-Ishizawa, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
悪性脳卒中易発性高血圧自然発症ラットの神経症状に対するニトロソニフェジピンの効果,
第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2015.
149. 戸谷 紘基, Keisuke Ishizawa, Yuki Izawa-Ishizawa, 細岡 真由子, 鍵本 優有, 斎藤 尚子, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
大動脈解離発症における内皮障害の関与の検討,
第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2015.
150. Yasumasa Ikeda, 佐藤 明穂, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄欠乏は骨格筋量減少の原因となる,
第39回日本鉄バイオサイエンス学会学術集会, Aug. 2015.
151. Ariunzaya Burentogtokh, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
YC1 increased adiponectin expression in 3T3-L1 adipocytes,
次世代を担う創薬・医療薬理シンポジウム2015, Aug. 2015.
152. Yuki Izawa-Ishizawa, Keisuke Ishizawa, 大越 瑞穂, 土肥 紗希子, Yoshitaka Kihira, Yasumasa Ikeda and Toshiaki Tamaki :
血管石灰化シグナルにおけるRhoキナーゼおよびサイクロフィリンAの関与,
第47回日本動脈硬化学会総会・学術集会, Jul. 2015.
153. Yasumasa Ikeda, Kanai Yusuke, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Bilirubin Promotes Ischemic-Induced Revascularization through Akt-eNOS Pathway,
第79回 日本循環器学会学術集会, Apr. 2015.
154. Yoshitaka Kihira, 岸渕 麗奈, Kunihisa Yamaguchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
腎虚血再灌流障害において低酸素誘導因子が制御する因子の探索,
日本薬学会第135年会(神戸), Mar. 2015.
155. Mai Takata, Keisuke Ishizawa, 田渕 正樹, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
悪性脳卒中易発性高血圧自然発症ラットに対するニトロソニフェジピンの効果,
日本薬学会第135年会(神戸), Mar. 2015.
156. Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
ビリルビンは虚血後血管新生を促進する,
第88回 日本薬理学会年会(愛知), Mar. 2015.
157. Yuki Izawa-Ishizawa, Keisuke Ishizawa, 田渕 正樹, Mai Takata, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンは悪性脳卒中易発性高血圧自然発症ラットの生存期間を延長させる,
第88回 日本薬理学会年会(愛知), Mar. 2015.
158. Hiroki Toya, Keisuke Ishizawa, Yuki Izawa-Ishizawa, Yusuke Kohara, Tomoko Nagao, 今西 正樹, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
大動脈解離発症における血管内皮機能障害の関与,
第88回 日本薬理学会年会(愛知), Mar. 2015.
159. 岸渕 麗奈, Yoshitaka Kihira, Kunihisa Yamaguchi, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia-inducible factor-1 participates in induction of apoptosis in renal reperfusion injury,
第88回 日本薬理学会年会(愛知), Mar. 2015.
160. Mizuho Ogoshi, Yuki Izawa-Ishizawa, Sakiko Doi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
血管平滑筋細胞において無機リンによる石灰化シグナルにはRho-kinaseおよびcyclophilin Aが関与する,
第88回 日本薬理学会年会(愛知), Mar. 2015.
161. Burentogtokh Ariunzaya, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia decreases glucagon-like peptide-1 secretion from glutag cell lines,
第88回 日本薬理学会年会(愛知), Mar. 2015.
162. Yasumasa Ikeda, 金井 佑亮, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
ビリルビンの血管新生促進作用の検討,
第44回 日本心脈管作動物質学会, Feb. 2015.
163. Yasumasa Ikeda, 金井 佑亮, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
ビリルビンは血管内皮細胞を活性化させて,虚血後血管新生を促進する,
第24回 循環薬理学会, Dec. 2014.
164. Yuki Izawa-Ishizawa, Keisuke Ishizawa, 長尾 朋子, 戸谷 紘基, 小原 佑介, 細岡 真由子, 高田 真衣, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
新規薬剤誘発性大動脈解離モデルを用いたスタチンの効果の検討,
第24回 循環薬理学会, Dec. 2014.
165. 岸渕 麗奈, Yoshitaka Kihira, Kunihisa Yamaguchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
低酸素誘導因子の機能不全は腎虚血再灌流障害からの回復を阻害する,
第36回 生体膜と薬物の相互作用シンポジウム, Nov. 2014.
166. Yoshitaka Kihira, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
高脂肪食誘発肥満に対する脂肪特異的低酸素誘導因子欠損の影響,
第36回 生体膜と薬物の相互作用シンポジウム, Nov. 2014.
167. 長尾 朋子, Keisuke Ishizawa, 戸谷 紘基, 小原 佑介, 今西 正樹, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
HMG-CoA 還元酵素阻害薬の大動脈解離に対する効果,
第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2014.
168. 小原 佑介, Keisuke Ishizawa, 櫻田 巧, 戸谷 紘基, 長尾 朋子, 壱岐 豊, 細岡 真由子, 今西 正樹, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
大動脈瘤形成に対する新規抗酸化薬の効果,
第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会, Nov. 2014.
169. 岸渕 麗奈, Yoshitaka Kihira, Kunihisa Yamaguchi, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
低酸素誘導因子の腎虚血再灌流障害に対する役割,
第126回日本薬理学会近畿部会, Oct. 2014.
170. 長尾 朋子, Keisuke Ishizawa, 戸谷 紘基, 小原 佑介, 今西 正樹, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
大動脈解離に対するピタバスタチンの効果,
第126回日本薬理学会近畿部会, Oct. 2014.
171. Yasumasa Ikeda, 今尾 瑞季, 佐藤 明穂, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄による骨格筋萎縮メカニズムの検討,
日本鉄バイオサイエンス学会 第38回学術集会, Sep. 2014.
172. 小原 佑介, Keisuke Ishizawa, 櫻田 巧, 戸谷 紘基, 長尾 朋子, 壱岐 豊, 細岡 真由子, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンは大動脈瘤の形成を抑制する,
次世代を担う創薬・医療薬理シンポジウム 2014, Aug. 2014.
173. 戸谷 紘基, Keisuke Ishizawa, 小原 佑介, 長尾 朋子, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
血管内皮障害を介する新規大動脈解離モデルの作製,
次世代を担う創薬・医療薬理シンポジウム 2014, Aug. 2014.
174. 小原 佑介, Keisuke Ishizawa, 櫻田 巧, 戸谷 紘基, 長尾 朋子, 壱岐 豊, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
薬剤誘導性大動脈瘤モデルに対するニトロソニフェジピンの効果,
第125回日本薬理学会近畿部会, Jun. 2014.
175. Yasumasa Ikeda, 田島 壮一郎, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Licht Miyamoto, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
アンジオテンシンIIは鉄吸収制御と生体内鉄分布変化に関与する,
第125回日本薬理学会近畿部会, Jun. 2014.
176. 今西 正樹, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Noriko Yamano, Koichiro Tsuchiya and Toshiaki Tamaki :
血管リモデリングにおける低酸素誘導因子HIF-1αの役割,
日本薬学会第134年会, Mar. 2014.
177. Yoshitaka Kihira, Ariunzaya BURENTOGTOKH, Mari Itoh, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
腸管L細胞のグルカゴン様ペプチド-1分泌に対する低酸素の影響,
日本薬学会第134年会, Mar. 2014.
178. Keisuke Ishizawa, Yuki Izawa-Ishizawa, Noriko Yamano, 布 あさ美, 今西 正樹, 櫻田 巧, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine ameliorates the progression of renal disease associated with endothelial dysfunction independently of eNOS,
第87回日本薬理学会年会, Mar. 2014.
179. Mizuki Imao, Yasumasa Ikeda, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The mechanism of sj=keletal muscle atroph induced by iron,
第87回日本薬理学会年会, Mar. 2014.
180. Yuki Izawa-Ishizawa, Le Nhat-Tu, 竹井 雄一郎, Heo Kyung-Sun, Lee Hakjoo, Smrcka Alan, Miller Benjamin, Ko Kyung-Ae, Ture Sara, Morrell Craig, 藤原 敬己, Masashi Akaike, Toshiaki Tamaki and 阿部 純一 :
Anti-inflammatory effects of statins and anti-malarial agents via endothelial ERK5 activation,
第87回日本薬理学会年会, Mar. 2014.
181. Yasumasa Ikeda, 田島 壮一郎, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
アンジオテンシンIIは十二指腸鉄輸送体発現とマクロファージ鉄量を増加させる,
第43回日本心脈管作動物質学会, Feb. 2014.
182. Masaki Imanishi, Shuhei Tomita, Hirotsugu Kurobe, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
薬剤誘導性大動脈瘤モデルにおける平滑筋由来hypoxia-inducible factor-1αの役割,
第23回日本循環薬理学会, Dec. 2013.
183. Yoshitaka Kihira, Shuhei Tomita, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
肥満に伴う脂肪組織炎症に対する低酸素誘導因子の役割,
第124回日本薬理学会近畿部会, Nov. 2013.
184. 布 あさ美, Keisuke Ishizawa, Noriko Yamano, Yuki Izawa-Ishizawa, 櫻田 巧, Masaki Imanishi, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
ニトロソニフェジピンは血管内皮機能を改善することで糖尿病性腎症の進展を抑制する,
第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Oct. 2013.
185. Yuta Suzuki, Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
平滑筋由来HIF-1 αがアンジオテンシンII 誘発血管リモデリングに関与するメカニズム,
第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Oct. 2013.
186. Masaki Murakami, Yusaku Maeda, Shuhei Tomita, Masaki Imanishi, Yoshitaka Kihira, Keisuke Ishizawa, Noriko Yamano, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
血管傷害モデルに伴う血管リモデリングにおける骨髄由来細胞のHIF1 αの役割,
第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Oct. 2013.
187. Mariko Miyake, Yoshitaka Kihira, Shuhei Tomita, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
脂肪細胞の低酸素誘導因子欠損による耐糖能改善メカニズムの解析,
第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Oct. 2013.
188. Yasumasa Ikeda, 田島 壮一郎, Mizuki Imao, Yuya Horinouchi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
フェリチンの炎症惹起作用,
第37回日本鉄バイオサイエンス学会, Sep. 2013.
189. Masaki Murakami, Shuhei Tomita, Yusaku Maeda, Masaki Imanishi, Noriko Yamano, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
血管傷害モデルに伴う血管リモデリング形成過程には,傷害部位に動員される骨髄由来細胞のHIFが関与する,
次世代を担う創薬・医療薬理シンポジウム2013, Aug. 2013.
190. Noriko Yamano, Keisuke Ishizawa, 小堀 浩幸, Maki Urushihara, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
糖尿病性腎症における腎内局所アンジオテンシノーゲンに対するニトロソニフェジピンの効果,
第123回日本薬理学会近畿部会, Jul. 2013.
191. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
血管平滑筋細胞のhypoxia-inducible factor-1αがangiotensinⅡ誘発血管リモデリング形成に関与するメカニズムの解析,
第34回日本炎症・再生医学会, Jul. 2013.
192. Keisuke Ishizawa, Noriko Yamano, Yuki Izawa-Ishizawa, 櫻田 巧, Masaki Imanishi, Asami Nuno, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンは血管内皮保護作用を示して糖尿病性腎症進展を抑制する,
第56回日本腎臓学会学術総会, May 2013.
193. Masaki Imanishi, Keisuke Ishizawa, Takumi Sakurada, Yuki Izawa-Ishizawa, Noriko Yamano, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
酸化ストレスに起因する心腎血管障害の克服を目指す新規治療薬開発,
日本薬学会第133年会, Mar. 2013.
194. Koichiro Tsuchiya, Yasumasa Ikeda, 田島 壮一郎, Yoshitaka Kihira, Keisuke Ishizawa, Yuki Izawa-Ishizawa, Licht Miyamoto, Noriko Yamano and Toshiaki Tamaki :
糖尿病に対する鉄の関与とキレート療法,
日本薬学会第133年会, Mar. 2013.
195. Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Hypoxia-inducible factor-1a; in vascular smooth muscle cells contributes to AT1 receptor expression in angiotensin II-induced vascular remodeling in mice,
第86回日本薬理学会年会, Mar. 2013.
196. Mari Itoh, Yoshitaka Kihira, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
Secretion of glucagon-like peptide-1 from Intestinal L cell in hypoxia,
第86回日本薬理学会年会, Mar. 2013.
197. 田島 壮一郎, Yasumasa Ikeda, Koichiro Tsuchiya, Yuya Horinouchi, Takumi Sakurada, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Kazuyoshi Kawazoe, Kazuo Minakuchi and Toshiaki Tamaki :
The influence of angiotensin II on duodenal iron absorption,
第86回日本薬理学会年会, Mar. 2013.
198. Yasumasa Ikeda, 田島 壮一郎, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Bovine lactoferrin stimulated angiogenesis in response to ischemic hindlimb,
第86回日本薬理学会年会, Mar. 2013.
199. Yuki Izawa-Ishizawa, Keisuke Ishizawa, Sakiko Doi, Masaki Imanishi, Takumi Sakurada, Noriko Yamano, Yusuke Kohara, Tomoko Nagao, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Y-27632, a rho-kinase inhibitor, inhibits inorganic phosphate-induced ERK1/2 phosphorylation and ALP activity in vascular smooth muscle cells,
第86回日本薬理学会年会, Mar. 2013.
200. Iori Ohzono, Yasumasa Ikeda, Souichirou Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
The Effects of Iron chelatoion against Renal Fibrosis in Unilateral Ureteral Obstruction Mice Model,
第86回日本薬理学会年会, Mar. 2013.
201. Yoji Hoshina, Yoshitaka Kihira, Shuhei Tomita, Mariko Miyake, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Adipocyte-specific hypoxia-inducible factor-1alpha knockout stimulated GLP-1 and insulin secretions in mice,
第86回日本薬理学会年会, Mar. 2013.
202. Noriko Yamano, Keisuke Ishizawa, Shoko Fujii, Asami Nuno, Masaki Imanishi, Takumi Sakurada, Yuta Suzuki, Furi Endo, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Effects of nitrosonifedipine on the diabetic nephropathy with the endothelial dysfunction,
第86回日本薬理学会年会, Mar. 2013.
203. Yasumasa Ikeda, Hideaki Enomoto, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Low Iron Diet Limits Development of Diabetic Nephropathy In db/db Mice,
第77回日本循環器学会学術集会, Mar. 2013.
204. Yuki Izawa-Ishizawa, Keisuke Ishizawa, Noriko Yamano, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Asami Nuno, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
ニトロソニフェジピンは血管内皮細胞障害を伴う糖尿病性腎症の進展を抑制する,
第42回日本心脈管作動物質学会, Feb. 2013.
205. 田島 壮一郎, Yasumasa Ikeda, Hideaki Enomoto, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya, Kazuo Minakuchi and Toshiaki Tamaki :
鉄制限食によってdb/dbマウスの糖尿病性腎症進展は抑制される,
第42回日本心脈管作動物質学会, Feb. 2013.
206. Sakiko Doi, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Yusuke Kohara, Tomoko Nagao, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
無機リン刺激による血管平滑筋細胞石灰化におけるRho-kinaseの関与,
第42回日本心脈管作動物質学会, Feb. 2013.
207. Yoshitaka Kihira, Shuhei Tomita, Mariko Miyake, Yoji Hoshina, Noriko Yamano, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
脂肪細胞特異的低酸素誘導因子欠損マウスに観察される耐糖能の改善にはglucagon-like peptide-1が関与する,
第42回日本心脈管作動物質学会, Feb. 2013.
208. Keisuke Ishizawa, Masaki Imanishi, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Angiotensin II慢性投与はhypoxia-inducible factor-1αを介して血管リモデリングを惹起する,
第33回日本臨床薬理学会学術総会, Dec. 2012.
209. Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
血管平滑筋細胞のhypoxia-inducible factor-1αがangiotensinⅡ誘発血管リモデリング形成に寄与するメカニズムの解析,
第22回日本循環薬理学会, Nov. 2012.
210. Yasumasa Ikeda, 田島 壮一郎, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
鉄吸収機構におけるAngiotensinⅡの効果の検討,
第122回日本薬理学会近畿部会, Nov. 2012.
211. Shoko Fujii, Keisuke Ishizawa, Takumi Sakurada, Noriko Yamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Asami Nuno, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Toshiaki Tamaki and Koichiro Tsuchiya :
Nifedipine 光分解産物であるnitrosonifedipine は糖尿病性腎症進展を抑制する,
第51回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会, Nov. 2012.
212. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
血管平滑筋細胞におけるHIF-1αのangiotensinⅡ誘発血管リモデリング形成およびAT1受容体発現への関与;平滑筋特異的HIF-1α遺伝子欠損マウスを用いた検討 The Role of HIF-1α in angiotensin Ⅱ-induced Vascular Remodeling and AT1 Receptor Expression in Vascular Smooth Muscle Cells,
第35回日本高血圧学会総会, Sep. 2012.
213. Asami Nuno, Keisuke Ishizawa, Shoko Fujii, 櫻田 巧, Noriko Yamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
糖尿病性腎症進展に対するニトロソニフェジピンの抑制作用,
次世代を担う創薬・医療薬理シンポジウム2012, Sep. 2012.
214. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
AngiotensinⅡ誘発血管リモデリングにおける血管平滑筋細胞内HIFシグナルの解析,
次世代を担う創薬・医療薬理シンポジウム2012, Sep. 2012.
215. 田島 壮一郎, Yasumasa Ikeda, Koichiro Tsuchiya, Yuya Horinouchi, 櫻田 巧, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
十二指腸からの鉄吸収に対するAngiotensinⅡの影響,
第36回日本鉄バイオサイエンス学会学術集会, Sep. 2012.
216. Yusaku Maeda, Shuhei Tomita, Masaki Murakami, Masaki Imanishi, Yoshitaka Kihira, Yasumasa Ikeda, Keisuke Ishizawa, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
血管傷害モデルに伴う血管リモデリング形成過程には,傷害部位に動員される骨髄由来細胞のHIFが関与する,
第121回日本薬理学会近畿部会, Jun. 2012.
217. Masaki Imanishi, Shuhei Tomita, Keisuke Ishizawa, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
平滑筋特異的hypoxia-inducible factor-1α欠損がangiotensin II誘発血管リモデリング形成に及ぼす影響,
第121回日本薬理学会近畿部会, Jun. 2012.
218. Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Yuki Izawa-Ishizawa, Licht Miyamoto, Noriko Yamano, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine はangiotensin II 誘発のマウス血管リモデリングを改善する,
第65回日本酸化ストレス学会学術集会, Jun. 2012.
219. Shoko Fujii, Keisuke Ishizawa, Takumi Sakurada, Masaki Imanishi, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
糖尿病モデルマウスにおいてニトロソニフェジピンは腎症の進展を抑制する,
第55回日本腎臓学会学術総会, Jun. 2012.
220. Mariko Miyake, Yoshitaka Kihira, Manami Hirata, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
脂肪細胞における低酸素誘導因子1a欠損は高脂肪食負荷による耐糖能異常の発現を抑制する,
日本薬学会第132年会, Mar. 2012.
221. Asami Nuno, Keisuke Ishizawa, 藤井 聖子, Yuki Izawa-Ishizawa, Masaki Imanishi, Takumi Sakurada, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
2型糖尿病性腎症に対するニトロソニフェジピンの効果,
日本薬学会第132年会, Mar. 2012.
222. Yasumasa Ikeda, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Bovine Lactoferin Promotes Angiogenesis Via Akt-eNOS Dependent Pathway in Vascular Endothelial Cells,
第76回日本循環器学会学術集会, Mar. 2012.
223. Hideaki Enomoto, Yasumasa Ikeda, 田島 壮一郎, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Protective effect of dietary iron restriction on diabetic nephropathy,
第85回日本薬理学会年会, Mar. 2012.
224. Noriko Yamano, Yasumasa Ikeda, Minoru Sakama, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Accumulated iron storage in high fat diet-induced obese and diabetic mice,
第85回日本薬理学会年会, Mar. 2012.
225. Shoko Fujii, Keisuke Ishizawa, Takumi Sakurada, Yuki Izawa-Ishizawa, Masaki Imanishi, Asami Nuno, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipine prevents the progression of diabetic nephropathy in type 2 diabetic mice,
第85回日本薬理学会年会, Mar. 2012.
226. Shuhei Tomita, Mitsuru Takaku, Noriko Yamano, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya and Toshiaki Tamaki :
Preoperative stabilization of HIF-1 by systemic introduction of dimethyloxalylglycine (DMOG), improves skin flap survival,
第85回日本薬理学会年会, Mar. 2012.
227. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
The inhibitory effects of smooth muscle cell-specific hypoxia-inducible factor-1a deficiency on angiotensin 2-induced vascular remodeling in mice,
第85回日本薬理学会年会, Mar. 2012.
228. Manami Hirata, Yoshitaka Kihira, Mariko Miyake, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
High fat diet-induced inflammation in adipose tissues is reduced in adipocyte-specific hypoxia-inducible factor-1a knockout mice,
第85回日本薬理学会年会, Mar. 2012.
229. Keisuke Ishizawa, Shoko Fujii, Asami Nuno, Yuki Izawa-Ishizawa, Masaki Imanishi, Takumi Sakurada, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipineは2型糖尿病モデルマウスにおける腎症進展を抑制する,
第41回心脈管作動物質学会, Feb. 2012.
230. Yoshitaka Kihira, Mariko Miyake, Manami Hirata, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
肥満に伴う耐糖能異常の発現に対する脂肪細胞の低酸素誘導因子の役割,
第41回心脈管作動物質学会, Feb. 2012.
231. Noriko Yamano, Yasumasa Ikeda, Minoru Sakama, Soichiro Tajima, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
The alternation of iron metabolism in high fat diet-induced obese and diabetic mice,
第34回日本分子生物学会年会, Dec. 2011.
232. Yasumasa Ikeda, Hideaki Enomoto, 田島 壮一郎, Yuki Izawa-Ishizawa, Yoshitaka Kihira, Keisuke Ishizawa, Shuhei Tomita, Koichiro Tsuchiya and Toshiaki Tamaki :
糖尿病腎症進展における鉄除去の効果,
腎と高血圧update, Dec. 2011.
233. Mitsuru Takaku, Shuhei Tomita, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Yasumasa Ikeda, Koichiro Tsuchiya, Hideki Nakanishi and Toshiaki Tamaki :
PHD阻害剤の虚血皮弁生存拡大に対する効果,
第21回日本循環薬理学会, Dec. 2011.
234. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Shuhei Tomita and Toshiaki Tamaki :
AngiotensinⅡ誘発性血管リモデリングは平滑筋特異的HIF-1α遺伝子欠損により抑制される,
第34回日本高血圧学会総会, Oct. 2011.
235. 田島 壮一郎, Yasumasa Ikeda, Koichiro Tsuchiya, Noriko Yamano, Yuya Horinouchi, Takumi Sakurada, Yoshitaka Kihira, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Kazuyoshi Kawazoe, Shuhei Tomita, Kazuo Minakuchi and Toshiaki Tamaki :
肥満の脂肪組織における鉄の役割,
第35回日本鉄バイオサイエンス学会学術集会, Sep. 2011.
236. Takumi Sakurada, Keisuke Ishizawa, Masaki Imanishi, Jumpei Taniguchi, Shoko Fujii, Asami Nuno, Yuta Suzuki, Yuki Izawa-Ishizawa, Koichiro Tsuchiya and Toshiaki Tamaki :
Nitrosonifedipineによるマウス血管リモデリング抑制機構の解明,
次世代を担う創薬・医療薬理シンポジウム2011, Aug. 2011.
237. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
Hypoxia-inducible factor-1a in vascular smooth muscle cells contributes to the development of angiotensin -induced vascular remodeling,
第43回日本動脈硬化学会 総会・学術集会, Jul. 2011.
238. Masaki Imanishi, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Noriko Yamano, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki and Shuhei Tomita :
AngiotensisⅡ誘発血管リモデリングは血管平滑筋細胞のhypoxia-inducible factor-1αを介して形成される,
第119回日本薬理学会近畿部会, Jul. 2011.
239. Yuki Izawa-Ishizawa, Taichi Murakami, 岸 史, Motokazu Matsuura, 近藤 直樹, Seiji Kishi, Kojiro Nagai, Hideharu Abe and Toshio Doi :
LDL吸着が複数回奏功した難治性ネフローゼ症候群の1例,
日本内科学会 第104会四国地方会, May 2011.
240. Hirotsugu Kurobe, Yuki Izawa, Yayoi Fukumura, Tamotsu Kanbara, Atsushi Kurushima, Ken-ichi Aihara, Masashi Akaike, Masashi Kano, Takashi Kitaichi, Yutaka Masuda, Hiroyuki Azuma, Toshiaki Tamaki, Toshio Matsumoto, Tetsuya Kitagawa, Shuhei Tomita and Masanori Yoshizumi :
HIF-ARNT transcriptional system in T cells has a pivotal role in vascular in flammation and remodeling.,
第70回日本循環器学会学術総会, Mar. 2006.
241. Hirotsugu Kurobe, Shuhei Tomita, Yuki Izawa, 福原 弥生, Tamotsu Kanbara, Ken-ichi Aihara, Masashi Akaike, Tetsuya Kitagawa, Toshio Matsumoto, Masanori Yoshizumi and Toshiaki Tamaki :
T細胞特異的HIF1αKOマイスではカフモデルにて血管リモデリングが促進される,
第15回日本循環薬理学会, Nov. 2005.

Et cetera, Workshop:

1. 池田 裕美子, 斎藤 尚子, Yuki Izawa-Ishizawa, Yuya Horinouchi, Yasumasa Ikeda, Keisuke Ishizawa and Toshiaki Tamaki :
ケルセチンによる血管保護効果の検討,
西日本医学生学術フォーラム(第5回医学研究学生フォーラム), Dec. 2016.
2. Yoshito Zamami, Masaki Imanishi, Kenshi Takechi, Yuya Horinouchi, Licht Miyamoto, Yuki Izawa-Ishizawa, Yasumasa Ikeda, Toshiaki Tamaki and Keisuke Ishizawa :
ドラッグリポジショニング手法を用いた新規循環器治療薬の探索研究,
第23回大阪市大フォーラム, Aug. 2016.
3. Yuki Izawa-Ishizawa :
「基礎」という選択,仕事と子育て,
第4回医学研究学生フォーラム, Dec. 2015.
4. Yuki Izawa-Ishizawa :
グローカルな視点から 女性研究者支援を考える,
四国5大学連携 女性研究者活躍推進シンポジウム2015, Dec. 2015.
5. Yuki Izawa-Ishizawa :
A Mom Takes "Research Leave" in Rochester, NY,
血管, Vol.37, No.2, 83-84, May 2014.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

  • Elucidation of the relationship between infectious diseases and aortic diseases by big data analysis and in vivo experiments (Project/Area Number: 21H02646 )
  • シナジー効果探索手法の構築と医療情報データベースへの適用 (Project/Area Number: 20H05798 )
  • 医療ビッグデータを活用した薬剤性腎障害予防を目指した最適な支持療法の確立 (Project/Area Number: 20K07132 )
  • がん転移制御に向けた内皮間葉転換機構とERK5の役割解明 (Project/Area Number: 19K07321 )
  • 医療ビッグデータと新規モデル動物を応用した大動脈解離発症の病態解明と予防法開発 (Project/Area Number: 18K06686 )
  • Effect of glucagon on antidiabetic effect induced by nitrite (Project/Area Number: 16K08550 )
  • Clarification of ERK5-mediated endothelial mesenchymal transition suppression mechanism and its application to the prevention of arteriosclerosis (Project/Area Number: 16K08549 )
  • Development of novel aortic dissection model based on vascular endothelial dysfunction and elucidation of pathophysiological mechanisms (Project/Area Number: 15K07967 )
  • Physiological role of dietary nitrite (Project/Area Number: 15H02898 )
  • The role of ERK5 in diabetic vascular calcification mediated by endothelial-to-mesenchymal transition (Project/Area Number: 26860172 )
  • The role of cyclophilin A in diabetic vascular calcification (Project/Area Number: 24790254 )
  • Search by Researcher Number (40610192)